NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Summary of Significant Accounting Policies
Xylem Inc. (“Xylem” or the “Company”) is a leading global water technology company. We design, manufacture and service engineered products and solutions across a wide variety of critical applications primarily in the water sector. Our broad portfolio of products, services and solutions addresses customer needs of scarcity, resilience, quality, and affordability across the water cycle, from the delivery, treatment, measurement and use of drinking water, to the collection, testing, analysis and treatment of wastewater, to the return of water to the environment.
Xylem operates in four segments, Water Infrastructure, Applied Water, Measurement and Control Solutions and Water Solutions and Services. See Note 21, "Segment and Geographic Data," for further segment background information.
Hereinafter, except as otherwise indicated or unless the context otherwise requires, “Xylem,” “we,” “us,” “our” and “the Company” refer to Xylem Inc. and its subsidiaries.
Basis of Presentation
The consolidated financial statements reflect our financial position and results of operations in conformity with accounting principles generally accepted in the United States of America (“GAAP”). All intercompany transactions between our businesses have been eliminated. Certain prior year amounts have been conformed to the current year presentation.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Estimates and assumptions are used for, but not limited to, post-retirement obligations and assets, revenue recognition, income taxes, fair value of assets acquired and liabilities assumed in business combinations, valuation of intangible assets, goodwill and indefinite-lived intangible impairment testing and contingent liabilities. Actual results could differ from these estimates.
Consolidation Principles
We consolidate companies in which we have a controlling financial interest or when Xylem is considered the primary beneficiary of a variable interest entity. We account for investments under the equity method in companies over which we have the ability to exercise significant influence but do not hold a controlling financial interest, and we record our proportionate share of income or losses in the Consolidated Income Statements. Equity method investments are reviewed for impairment when events or circumstances indicate the investment may be other than temporarily impaired. This requires significant judgment, including an assessment of the investee’s financial condition, the possibility of subsequent rounds of financing, and the investee’s historical and projected results of operations. If the actual results of operations for the investee are significantly different from projections, we may incur future charges for the impairment of these investments.
Foreign Currency Translation
The national currencies of our foreign companies are generally the functional currencies. Balance sheet accounts are translated at the exchange rate in effect at the end of each period; income statement accounts are translated at the average rates of exchange prevailing during the period. Gains and losses on foreign currency translations are reflected in the cumulative translation adjustments component of stockholders’ equity. Net gains or losses from foreign currency transactions are reported currently in selling, general and administrative expenses.
Revenue Recognition
Xylem recognizes revenue in a manner that depicts the transfer of promised goods and services to customers in an amount that reflects the consideration to which it expects to be entitled for providing those goods and services. For each arrangement with a customer, we identify the contract and the associated performance obligations within the contract, determine the transaction price of that contract, allocate the transaction price to each performance obligation and recognize revenue as each performance obligation is satisfied.
The satisfaction of performance obligations in a contract is based upon when the customer obtains control over the asset. Depending on the nature of the performance obligation, control transfers either at a particular point in time, or over time, which determines the pattern of revenue recognition.
For product sales, other than long-term construction-type contracts, we recognize revenue once control has passed at a point in time, which is generally when products are shipped. In instances where contractual terms include a provision for customer acceptance, revenue is recognized when either (i) we have previously demonstrated that the product meets the specified criteria based on either seller or customer-specified objective criteria or (ii) upon formal acceptance received from the customer where the product has not been previously demonstrated to meet customer-specified objective criteria. We recognize revenue on product sales to channel partners, including resellers, distributors or value-added solution providers, at the point in time when control is transferred which is determined based on when the risks and rewards, possession, and title have transferred to the customer, which usually occurs at the point of delivery.
Service revenue is primarily related to outsourced water services, maintenance, repair, preventive and inspection services, software as a service ("SaaS") subscriptions, and spare parts sales related to these service offerings. Revenue from performance obligations related to services is primarily recognized over time, as the performance obligations are satisfied. In these instances, the customer consumes the benefit of the service as Xylem performs.
Certain businesses also enter into long-term construction-type sales contracts where revenue is recognized over time. In these instances, revenue is recognized using a measure of progress that applies an input method based on costs incurred in relation to total estimated costs. We also recognize revenue for certain of these arrangements using the output method and measure progress based on shipments of product where control has transferred to the customer.
If shipping and handling activities are performed after a customer obtains control of a good, we account for the shipping and handling activities as activities to fulfill a promise to transfer a good. Shipping and handling related costs are accrued as revenue is recognized.
For all contracts with customers, we determine the transaction price in the arrangement and allocate the transaction price to each performance obligation identified in the contract. Judgment is required to determine the appropriate unit of account, and we separate the performance obligations if they are capable of being distinct and are distinct within the context of the contract. We base our allocation of the transaction price to the performance obligations on the relative stand-alone selling prices for the goods or services contained in a particular performance obligation. The stand-alone selling prices are determined first by reference to observable prices. In the event observable prices are not available, we estimate the stand-alone selling price by maximizing observable inputs and applying an adjusted market assessment approach, expected cost plus margin approach, or a residual approach in limited situations. Revenue in these instances is recognized on individual performance obligations within the same contract as they are satisfied.
The transaction price is adjusted for our estimate of variable consideration which may include a right of return, discounts, rebates, penalties, retainage, and warranties. To estimate variable consideration, we apply the expected value or the most likely amount method, based on whichever method most appropriately predicts the amount of consideration we expect to receive. The method applied is typically based on historical experience and known trends. We limit the amounts of variable consideration that are included in the transaction price, to the extent that it is probable that a significant reversal in the amount of cumulative revenue recognized will not occur or when uncertainties around the variable consideration are resolved.
We exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected from a customer, for example sales, use, value added and some excise taxes.
For all contracts with customers, payment received for our products and services may not necessarily follow the same pattern of revenue recognition to which it relates and are dictated by the terms and conditions of our contracts with customers. Payments received for product sales typically occur following delivery and the satisfaction of the performance obligations based upon the terms outlined in the contracts. Payments received for services typically occur following the services being rendered. For long-term construction-type projects, payments are typically made throughout the contract as progress is made.
In limited situations, contracts with customers include financing components where payment terms exceed one year; however, we believe that the financing effects are not significant to Xylem. In addition, we apply a practical expedient and do not adjust the promised amount of consideration in a contract for the effects of significant
financing components when we expect payment terms to be one year or less from the time the goods or services are transferred until ultimate payment.
We offer standard warranties for our products to enable compliance with agreed-upon specifications in our contracts. Standard warranties do not give rise to performance obligations and represent assurance-type warranties. In certain instances, product warranty terms are adjusted to account for the specific nature of the contract. In these instances, we assess the warranties to determine whether they represent service-type warranties, and should be accounted for as a separate performance obligation in the contract.
Costs to obtain a contract include incremental costs that the Company has incurred that it expects to recover. Incremental costs only include costs that the Company would not have incurred had the contract not been obtained. Costs that would have been incurred regardless of whether or not the contract was obtained are expensed as incurred, unless they are explicitly chargeable to the customer whether or not the contract is obtained.
Costs to obtain contracts are capitalized when incurred, and are then amortized in a manner that is consistent with the pattern of transfer of the related goods or services provided in the contract. The Company elects to apply the practical expedient to expense costs to obtain contracts when the associated amortization period of those costs would be one year or less.
Shipping and Handling Costs
Shipping and handling costs are recorded as a component of cost of revenue.
Share-Based Compensation
Share-based awards issued to employees include non-qualified stock options, restricted stock units and performance share units. Share-based awards issued to members of the Board of Directors include restricted stock units. Compensation costs resulting from share-based payment transactions are recognized primarily at fair value over the requisite service period (typically three years), on a straight-line basis, within selling, general and administrative expenses. The measurement of calculated compensation cost includes an adjustment for estimated forfeiture rate. The fair value of a non-qualified stock option is determined on the date of grant using a binomial lattice pricing model incorporating multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The fair value of restricted stock unit awards is determined using the closing price of our common stock on date of grant. The fair value of Return on Invested Capital ("ROIC"), Revenue, adjusted EBITDA and Earnings Per Share ("EPS") performance share units at 100% target is determined using the closing price of our common stock on date of grant. The calculated compensation cost is adjusted based on an estimate of awards ultimately expected to vest due to our assessment of the probable outcome of the performance condition. The fair value of Total Shareholder Return ("TSR") performance share units is calculated on the date of grant using a Monte Carlo simulation model utilizing several key assumptions, including expected Company and peer company share price volatility, correlation coefficients between peers, the risk-free rate of return, the expected dividend yield and other award design features.
Research and Development
We conduct research and development activities, which consist primarily of the development of new products, product applications, and manufacturing processes. To the extent these activities involve developing software that is sold to our customers, we capitalize the applicable development costs. All other research and development costs are charged to expense as incurred.
Exit and Disposal Costs
We periodically initiate management-approved restructuring activities to achieve cost savings through reduced operational redundancies and to position ourselves strategically in the market in response to prevailing economic conditions and associated customer demand. Costs associated with restructuring actions can include severance, acceleration of share-based compensation expense due to "double trigger" change in control provisions, infrastructure charges to vacate facilities or consolidate operations, contract termination costs and other related charges. For involuntary separation plans, a liability is recognized when it is probable and reasonably estimable. For voluntary separation plans, a liability is recognized when the employee irrevocably accepts the voluntary termination. For one-time termination benefits, such as additional severance pay or benefit payouts and other exit costs, the liability is measured and recognized initially at fair value in the period in which the liability is incurred, with subsequent changes to the liability recognized as adjustments in the period of change.
Deferred Financing Costs
Deferred financing costs represent costs incurred in conjunction with our debt financing activities and are capitalized in long-term debt and amortized over the life of the related financing arrangements. If the debt is retired early, the related unamortized deferred financing costs are recorded within the results of operations under the caption “interest expense” in the period the debt is retired.
Income Taxes
Income taxes are calculated using the asset and liability method. Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities, applying enacted tax rates in effect for the year in which we expect the differences will reverse.
We maintain valuation allowances when it is more likely than not that all or a portion of a deferred asset will not be realized. In determining whether a valuation allowance is warranted, we consider all positive and negative evidence and all sources of taxable income such as prior earnings history, expected future earnings, carryback and carryforward periods and tax strategies to estimate if sufficient future taxable income will be generated to realize the deferred tax asset. The assessment of the adequacy of our valuation allowance is based on our estimates of taxable income by jurisdiction in which we operate and the period over which our deferred tax assets will be recoverable. If actual results differ from these estimates, or we adjust these estimates in future periods for current trends or expected changes in our estimating assumptions, we may need to modify the level of valuation allowance that could materially impact our business, financial condition and results of operations.
We have recorded net foreign withholding taxes and state income taxes on earnings that are expected to be repatriated to the U.S. parent. We have not recorded any deferred taxes on the amounts that the Company currently does not intend to repatriate. The determination of deferred taxes on this amount is not practicable.
Tax benefits are recognized for an uncertain tax position when, based on the technical merits of the position it is more likely than not that the position will be sustained upon examination by a taxing authority or upon completion of the litigation process. For a tax position that meets the more-likely-than-not recognition threshold, the tax benefit is measured as the largest amount that is judged to have a greater than 50% likelihood of being realized upon ultimate settlement with a taxing authority. The liability associated with unrecognized tax benefits is adjusted periodically due to changing circumstances and when new information becomes available. Such adjustments are recognized in the period in which they are identified. The effective tax rate includes the net impact of changes in the liability for unrecognized tax benefits and subsequent adjustments as considered appropriate by management. While it is often difficult to predict the final outcome or the timing of resolution of any particular tax matter, we believe our liability for unrecognized tax benefits is adequate. We classify interest relating to unrecognized tax benefits as a component of other non-operating (expense) income, net and tax penalties as a component of income tax expense in our Consolidated Income Statements.
Earnings Per Share
We present two calculations of EPS. “Basic” EPS equals net income divided by weighted average shares outstanding during the period. “Diluted” EPS equals net income divided by the sum of weighted average common shares outstanding during the period plus potentially dilutive shares. Potentially dilutive common shares that are anti-dilutive are excluded from diluted EPS.
Cash Equivalents
We consider all liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Receivables and Allowance for Credit Losses and Discounts
Receivables are primarily comprised of uncollected amounts owed to us from transactions with customers and are presented net of allowances for credit losses, returns and early payment discounts.
We determine our allowance for credit losses using a combination of factors to reduce our trade receivable balances to the net amount expected to be collected. We maintain an allowance for credit losses based on a variety of factors, including the length of time receivables were past due, macro-economic trends and conditions, significant one-time events, historical experience, and current and future expectations of economic conditions. In addition, we record an allowance for individual accounts when we become aware of specific customer circumstances, such as in the case of bankruptcy filings or deterioration in the customer’s operating results or financial position. The past due or delinquency status of a receivable is based on the contractual payment terms of the receivable. If circumstances
related to the specific customer change, we adjust estimates of the recoverability of receivables as appropriate. We determine our allowance for early payment discounts primarily based on historical experience with customers.
Credit risk with respect to accounts receivable is generally diversified due to the large number of entities comprising our customer base and their dispersion across many different geographical regions. We evaluate the financial condition of our third-party distributors, resellers and other customers and require collateral, such as letters of credit and bank guarantees, in certain circumstances. As of December 31, 2025 and 2024, we do not have any significant concentrations of credit risk related to accounts receivable.
Inventories
Inventories, which include the costs of material, labor and overhead, are stated at the lower of cost or net realizable value. Estimated losses from obsolete and slow-moving inventories are recorded to reduce inventory values to their estimated net realizable value. Our manufacturing operations recognize costs of sales using standard costs with full overhead absorption, which generally approximates actual cost.
Property, Plant and Equipment
These assets are recorded at historical cost and are depreciated using the straight-line method of depreciation over the estimated useful lives as follows:
| | | | | |
| | Estimated Life |
| Buildings and improvements | 5 to 40 years |
| Machinery and equipment | 2 to 10 years |
| Furniture and fixtures | 3 to 7 years |
| Equipment held for lease or rental | 2 to 16 years |
Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the lease. Costs related to maintenance and repairs that do not prolong the assets' useful lives are expensed as incurred.
Leases
We determine if an arrangement is a lease at inception. We have recorded right of use (“ROU”) assets and liabilities for lease arrangements that are reasonably certain to extend beyond 12 months. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments under the lease. ROU assets and liabilities are recognized at lease commencement date based on the present value of lease payments over the lease term. The implicit rate within our leases is generally not determinable, and we use our incremental borrowing rate at the lease commencement date to determine the net present value of lease payments. The determination of the appropriate incremental borrowing rate requires judgment. We determine the appropriate incremental borrowing rate for each lease using our current borrowing rate, adjusted for various factors including geographic region, level of collateralization and term, to align with the term of the underlying lease.
Lease expense for lease payments is recognized on a straight-line basis over the lease term. Many of our leases are subject to payment adjustments to reflect annual changes in price indexes, such as the Consumer Price Index. While associated lease liabilities are not re-measured as a result of changes in the applicable price indexes, changes to required lease payments are treated as variable lease payments and recognized in the period in which the obligation for those payments was incurred.
Leases with a lease term of 12 months or less, including renewal options that are reasonably certain to be exercised, that also do not include an option to purchase the underlying asset that is reasonably certain of exercise, are not recorded on the Consolidated Balance Sheets. Instead, lease payments for these leases are recognized as a lease cost on a straight-line basis over the lease term.
We elected the package of practical expedients, which among other things, does not require reassessment of lease classification. Additionally, we have made an accounting policy election whereby we chose not to separate non-lease components from lease components in agreements in all leases which we are the lessee.
In addition to manufacturing and selling equipment, we also lease equipment to customers in exchange for consideration. These arrangements are generally short term in nature and predominantly involve the rental of pumps and accessories within the Water Solutions and Services segment. Short term rental arrangements generally do not provide the customer the right to purchase the equipment as Xylem’s strategy is to rent these items over their useful lives. Customers may be billed based on daily, weekly or monthly rates depending on the expected rental period. We assessed that these arrangements constitute a lease under Accounting Standards Codification ("ASC") 842, Leases, and have recognized them as operating leases. In situations where arrangements contain both the
sale of products and a leasing component, contract consideration is allocated based on relative standalone selling price.
The Company also generates revenue through the lease of its water treatment equipment and systems to customers within the Water Solutions and Services segment. At the time of contract inception, the Company determines if an arrangement is or contains a lease. These contracts generally contain both lease and non-lease components, including installation, maintenance, and monitoring services of the Company-owned equipment. In situations where arrangements contain multiple elements, contract consideration is allocated based on relative standalone selling price.
Goodwill and Intangible Assets
Goodwill represents purchase consideration paid in a business combination that exceeds the values assigned to the net assets of acquired businesses. Intangible assets include customer relationships, proprietary technology, brands and trademarks, patents, software and other intangible assets. Intangible assets with a finite life are amortized on a straight-line basis over an estimated economic useful life which ranges from 1 to 40 years and is included in cost of revenue or selling, general and administrative expenses. Certain of our intangible assets, namely certain brands and trademarks, as well as FCC licenses, have an indefinite life and are not amortized.
Goodwill and indefinite-lived intangible assets are not amortized, but rather are tested for impairment annually (or more frequently if impairment indicators arise, such as changes to the reporting unit structure, significant adverse changes in the business or business climate or an adverse action or assessment by a regulator). See Note 12, "Goodwill and Other Intangible Assets," for changes to the reporting unit structure and impairment analysis performed during the year ending December 31, 2025. We conduct our annual impairment testing as of the beginning of the fourth quarter. To test goodwill for impairment, the estimated fair value of each reporting unit is compared to the carrying value of the net assets assigned to that reporting unit. If the estimated fair value of the reporting unit exceeds its carrying value, goodwill is not impaired. If the carrying value of the reporting unit exceeds its estimated fair value, then an impairment charge is recognized for that excess up to the amount of recorded goodwill. In assessing goodwill for impairment, we estimate the fair value of our reporting units using both the income approach and market approach. Weighting is equally attributed to both the market and income approaches in arriving at the fair value of the reporting units. To determine the reasonableness of the calculated fair values, we review the assumptions to ensure that neither the income approach nor the market approach yielded significantly different valuations. We estimate the fair value of our intangible assets with indefinite lives using either the income approach or the market approach. Under the income approach, we calculate fair value based on the present value of estimated future cash flows. Under the market approach, we calculate fair value based on recent sales and selling prices of similar assets.
Long-Lived Asset Impairment
Long-lived assets, including intangible assets with finite lives, are amortized and tested for impairment whenever events or changes in circumstances indicate their carrying value may not be recoverable. We assess the recoverability of long-lived assets based on the undiscounted future cash flow the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. When an impairment is identified, we reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flow approach or, when available and appropriate, to comparable market values.
Product Warranties
For assurance-type warranties, we accrue for the estimated cost of product warranties at the time revenue is recognized and record it as a component of cost of revenue. Our product warranty liability reflects our best estimate of probable liability under the terms and conditions of our product warranties offered to customers. We estimate the liability based on our standard warranty terms, the historical frequency of claims and the cost to replace or repair our products under warranty. Factors that impact our warranty liability include the number of units sold, the length of warranty term, historical and anticipated rates of warranty claims and cost per claim. We also record a warranty liability for specific matters. We assess the adequacy of our recorded warranty liabilities quarterly and adjust amounts as necessary.
For service-type warranties (i.e. non-standard warranties) costs incurred to fulfill the extended or service warranty are recognized/recorded as the costs are incurred.
Post-retirement Benefit Plans
The determination of defined benefit pension and post-retirement plan obligations and their associated costs requires the use of actuarial computations to estimate participant plan benefits to which the employees will be entitled. The assumptions primarily relate to discount rates, expected long-term rates of return on plan assets, rate of future compensation increases, mortality, years of service and other factors. We develop each assumption using relevant company experience in conjunction with market-related data for each individual country in which such plans exist. All actuarial assumptions are reviewed annually with third-party consultants and adjusted as necessary. For the recognition of net periodic post-retirement cost, the calculation of the expected return on plan assets is generally derived by applying the expected long-term rate of return on the market-related value of plan assets. The market-related value of plan assets is based on average asset values at the measurement date over the last five years. Actual results that differ from our assumptions are accumulated and amortized on a straight-line basis only to the extent they exceed 10% of the higher of the market-related value or the projected benefit obligation, over the average remaining service period of active participants, or for plans with all or substantially all inactive participants, over the average remaining life expectancy. The fair value of plan assets is determined based on market prices or estimated fair value at the measurement date.
We consider changes to a plan’s benefit formula that eliminate the accrual for future service but continue to allow for future salary increases (i.e. “soft freeze”) to be a curtailment.
Business Combinations
We allocate the purchase price of acquisitions to the tangible and intangible assets acquired, liabilities assumed, and non-controlling interests in the acquiree based on their estimated fair value at the acquisition date. The excess of the acquisition price over those estimated fair values is recorded as goodwill. Changes to the acquisition date provisional fair values prior to the expiration of the measurement period, a period not to exceed 12 months from date of acquisition, are recorded as an adjustment to the associated goodwill. Acquisition-related expenses and restructuring costs, if any, are recognized separately from the business combination and are expensed as incurred.
Assets Held for Sale
Assets and liabilities are identified as held for sale when they meet the held for sale criteria per ASC 360, Property, Plant, and Equipment. Depreciation and amortization are not recorded for assets that are classified as held for sale. When an asset group meets the held for sale criteria, the lower of its carrying value or fair value less costs to sell is reclassified into assets held for sale and liabilities held for sale lines on the consolidated balance sheet, where it remains until it is either sold or it no longer meets the held for sale criteria.
Derivative Financial Instruments
We record all derivatives on the Consolidated Balance Sheets at fair value. The accounting for changes in the fair value of derivatives depends on whether we have elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, including forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. We may enter into derivative contracts that are intended to hedge certain risks economically, even though hedge accounting does not apply or we elect not to apply hedge accounting.
Changes in the fair value of derivatives designated and that qualify as cash flow hedges of foreign exchange risk are recorded in Other Comprehensive Income (Loss) ("OCI/L") and are subsequently reclassified into either revenue or cost of revenue (hedge of sales classified into revenue and hedge of purchases classified into cost of revenue) in the period that the hedged forecasted transaction affects earnings. Our policy is to de-designate cash flow hedges at the time forecasted transactions are recognized as assets or liabilities on a business unit’s balance sheet and report subsequent changes in fair value through selling, general and administrative expenses where the gain or loss due to movements in currency rates on the underlying asset or liability is revalued. If it becomes probable that the originally forecasted transaction will not occur, the gain or loss related to the hedge recorded within Accumulated Other Comprehensive Loss ("AOCL") is immediately recognized into net income.
Effectiveness of derivatives designated as net investment hedges is assessed using the spot method. The changes in the fair value of these derivatives due to movements in spot exchange rates are recorded in OCI/L. Changes in fair value of the derivatives designated and the associated income tax effects in AOCL are reclassified into earnings at the time the hedged net investment is sold or substantially liquidated. Furthermore, we recognize interest income based on the interest rate differential embedded in the derivative instrument.
Commitments and Contingencies
We record accruals for commitments and loss contingencies for those which are both probable and for which the amount can be reasonably estimated. In addition, legal fees are accrued for cases where a loss is probable and the related fees can be reasonably estimated. Significant judgment is required to determine both probability and the estimated amount of loss. We review these accruals quarterly and adjust the accruals to reflect the impact of negotiations, settlements, rulings, advice of legal counsel, and other current information.
Accruals for environmental matters are recorded on a site-by-site basis when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. Our estimated liability is reduced to reflect the anticipated participation of other potentially responsible parties in those instances where it is probable that such parties are legally responsible and financially capable of paying their respective shares of the relevant costs. These accruals are reviewed quarterly and are adjusted as assessment and remediation efforts progress, or as additional technical or legal information becomes available. Actual costs to be incurred at identified sites in future periods may vary from the estimates, given inherent uncertainties in evaluating environmental exposures. Accruals for environmental liabilities are primarily included in other non-current liabilities at undiscounted amounts.
Concentrations of Credit Risk
Financial instruments that potentially subject us to significant concentrations of credit risk consist principally of cash and cash equivalents, derivative contracts and accounts receivable from trade customers. We maintain cash and cash equivalents and derivative contracts with various financial institutions. These financial institutions are located in many different geographical regions, and our policy is designed to limit exposure with any one institution. As part of our cash and risk management processes, we perform periodic evaluations of the relative credit standing of the financial institutions. We have not sustained any material credit losses during the previous three years from instruments held at financial institutions. We may utilize forward contracts to protect against the effects of foreign currency fluctuations. Such contracts involve the risk of non-performance by the counterparty. Credit risk with respect to accounts receivable is generally diversified due to the large number of entities comprising our customer base and their dispersion across many different industries and geographic regions. We perform ongoing credit evaluations of the financial condition of our third-party distributors, resellers and other customers and require collateral, such as letters of credit and bank guarantees, in certain circumstances.
Substantially all of the cash and cash equivalents, including foreign cash balances, at December 31, 2025 and 2024 were uninsured. Foreign cash balances at December 31, 2025 and 2024 were $1,034 million and $741 million, respectively.
Fair Value Measurements
We determine fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We use a hierarchical structure to prioritize the inputs to valuation techniques used to measure fair value into three broad levels defined as follows:
•Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
•Level 2 inputs are other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices (in non-active markets or in active markets for similar assets or liabilities), inputs other than quoted prices that are observable, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
•Level 3 inputs are unobservable inputs for the assets or liabilities.
The fair value hierarchy is based on maximizing the use of observable inputs and minimizing the use of unobservable inputs when measuring fair value. Classification within the fair value hierarchy is based on the lowest level input that is significant to the fair value measurement.
Certain investments which measure fair value using the net asset value (“NAV”) per share practical expedient are not classified within the fair value hierarchy and are separately disclosed.
Redeemable Non-Controlling Interest
Non-controlling interest that is redeemable upon the occurrence of an event that is not solely within the control of the issuer is classified as mezzanine equity in the Company’s consolidated balance sheets. Initial measurement is at acquisition date fair value and subsequent measurement is at the greater of the carrying value or the redemption value. For redeemable non-controlling interests measured at the redemption value, changes in the redemption value are recognized immediately as they occur and the carrying amount of the redeemable non-controlling interest is adjusted at the end of each reporting period. This method views the end of the reporting period as if it were also the redemption date for the instrument. Increases or decreases in the estimated redemption amount are recorded with corresponding adjustments against equity and are reflected in the computation of earnings per share.
Note 2. Recently Issued Accounting Pronouncements
Pronouncements Not Yet Adopted
In September 2025, the FASB issued ASU No. 2025-06, “Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software”. This ASU amends the capitalization criteria for internal-use software and requires entities to make certain disclosure of costs capitalized under this subtopic. This ASU also supersedes existing guidance on web site development costs. The standard is effective for annual reporting periods beginning after December 15, 2027, and interim reporting periods within those annual reporting periods, with early adoption permitted. Prospective, retrospective, or modified transition adoption methods are all permitted under this ASU. We are currently evaluating the impact and method of adoption of this amendment.
In July 2025, the FASB issued ASU 2025-05, "Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets". This update provides a practical expedient that allows entities to assume current conditions as of the balance sheet date remain unchanged over the remaining life of certain current trade receivables and current contract assets when developing reasonable and supportable forecasts in estimating expected credit losses. We plan to adopt ASU 2025-05 effective January 1, 2026 and elect the practical expedient for applicable trade receivables and contract assets on a prospective basis. Adoption of the standard is not expected to have a material impact on our consolidated financial statements.
In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, "Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses". This ASU requires a footnote disclosure to disaggregate each relevant expense caption on the face of the income statement that includes specific natural expense categories. In addition, the standard requires disclosure of selling expenses on an annual and interim basis. The standard is effective in annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The standard is required to be adopted prospectively, but retrospective adoption is permitted. We are currently evaluating the method of adoption and the impacts of the guidance on our disclosures in future periods.
Recently Adopted Pronouncements
In December 2023, the FASB issued ASU No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures". The ASU is intended to improve income tax disclosure requirements, primarily through additional disclosures about a reporting entity’s effective tax rate reconciliations as well as information on income taxes paid. The standard became effective for Xylem for the annual reporting period beginning January 1, 2025, which we adopted prospectively. The disclosures related to our adoption of the amendment are included in Note 7, "Income Taxes."
Note 3. Acquisitions and Divestitures
2025 Asset Acquisition
Vacom Systems, LLC
At the beginning of the second quarter, we acquired Vacom Systems, LLC ("Vacom"), a wastewater treatment company that specializes in non-fouling, non-scaling evaporator and crystallizer systems, headquartered in Utah, U.S. The transaction has a total cash consideration of $42 million, of which $37 million was paid at closing. The remaining cash consideration will be paid over the next 12 to 18 months, subject to working capital and other customary adjustments. Additionally, the transaction consideration contained an earn out of 5% royalty on future revenue generated in connection with Vacom's proprietary technologies during the first five years following the acquisition. The earn out has a maximum pay out of $25 million.
The Vacom transaction was accounted for as an asset acquisition because substantially all of the fair value of gross assets acquired were concentrated in its developed technology. On the acquisition date, the developed technology recognized in the condensed consolidated balance sheet is $49 million. The developed technology has a useful life of 15 years and will be amortized over its useful life on a straight-line basis within the Water Solutions and Services segment.
2025 Business Combination
Pac Machine
On December 2, 2025, we acquired Pac Machine Company ("Pac Machine"), a leading distributor specializing in the sale, rental and service of pumps, generators, and other dewatering equipment for mining, construction, agriculture, energy and marine sectors. The acquisition strengthens the Company's presence in Northern California and Nevada, while providing synergy opportunities. The total fair value of consideration transferred was $63 million ($59 million net of cash), of which $54 million ($50 million, net of cash) was paid at closing. The remaining consideration of $9 million will be paid over the next four years, subject to working capital and other customary adjustments. As a result of purchase price allocation, we provisionally recognized $19 million of intangible assets, and $34 million of goodwill, subject to future measurement period adjustments. Our consolidated financial statements include Pac Machine's results of operations within the Water Solutions and Services segment.
EMX Holdings, Inc.
On July 23, 2025, we acquired 100% ownership interest in EMX Holdings, Inc. and its subsidiary ("EnviroMix"). EnviroMix is headquartered in South Carolina, U.S., and provides mixing and process control products and services to municipal and industrial customers. This acquisition expands the Company's treatment offerings and provides synergy opportunities. The operating results of EnviroMix have been included in the Company's results of operations since the acquisition date within the Water Infrastructure segment.
The total fair value of consideration transferred was $106 million, which was paid in cash on closing date, subject to final closing working capital and other ordinary adjustments. The fair value of assets and liabilities acquired resulting from the preliminary purchase price allocation consisted primarily of $76 million in goodwill and $34 million for customer relationships and other identifiable intangible assets. The preliminary estimates of fair value of EnviroMix’s identifiable intangible assets were valued using the multi-period excess earnings method (“MEEM”), the relief from royalty (“RFR”) method, or the with and without method, all of which are forms of the income approach. The amount of goodwill recognized in the acquisition is not deductible for U.S. income tax purposes and is primarily attributable to management know-how and costs and revenue synergies expected from combining the operations of EnviroMix with Xylem.
The final determination of the fair value of certain assets and liabilities will be completed as soon as the necessary information becomes available but no later than one year from the acquisition date. Pro forma results of operations have not been included as the acquisition of EnviroMix was not material to our results of operations for any periods presented.
Simply Clean Air and Water, Inc.
On January 31, 2025, we acquired Simply Clean Air and Water, Inc. ("Simply Clean"), a water service company that specializes in high-purity water systems for life sciences and pharmaceutical markets, for the net cash acquisition price of $7 million. The company is headquartered in Connecticut, U.S. with 20 employees. Our consolidated financial statements include Simply Clean's results of operations within the Water Solutions and Services segment.
2025 Divestiture
On February 7, 2025, we completed the divestiture of our previously held for sale Evoqua Magneto business, which was part of the Water Infrastructure segment, for a cash selling price of $61 million ($48 million, net of cash transferred). As a result of the sale, we recorded an additional loss of $8 million, reflecting the impact of the final working capital adjustment. The loss is presented on our Consolidated Income Statements within "Loss on sale of businesses" in the year ended December 31, 2025.
The Company also completed certain other divestitures, which generated aggregate cash proceeds of approximately $1 million.
2025 Assets Held For Sale
On September 27, 2025, the Company signed an agreement to sell the international metering business, a part of the Measurement and Control Solutions segment, within one year. The international metering business offers a portfolio of water and heat meters for residential, commercial, and industrial applications. As a result, assets and liabilities of the business were reclassified as held for sale.
During the year ended December 31, 2025, the Company recorded a loss on assets held for sale of $23 million because the carrying value of the international metering business is greater than its estimated fair value less its cost to sell. The loss is presented within "Loss on sale of businesses" on our Consolidated Income Statements.
2024 Business Combination
Global Omnium Idrica, S.L.
On April 26, 2023, we acquired a 25.1% equity interest in Global Omnium Idrica S.L. (“Idrica”), a global company specializing in digital transformation for the water industry, offering innovative services and technological solutions for comprehensive water cycle management for $51 million. In connection with the transaction, the Company was granted the right to purchase a majority interest in Idrica from the joint venture partner at a fixed price. The investment was accounted for as an equity method investment as the Company had significant influence but did not have control over Idrica.
On December 10, 2024, we acquired an additional 35.9% equity interest in Idrica for $154 million ($150 million, net of cash received) by exercising our call right and now hold an aggregate ownership interest of 61.0% in Idrica. This was accounted for as a step acquisition where the Company has applied the acquisition method of accounting in accordance with ASC 805, Business Combinations (“ASC 805”). The fair value of our call right was included within the fair value of previously held equity interest and recognized as part of the consideration transferred and the gain on remeasurement of our call right was also included in the gain on remeasurement of previously held equity interest (as discussed below). The Company recognized assets acquired and liabilities assumed at their fair value as of the date of acquisition, with the excess purchase consideration recorded to goodwill.
The total fair value of consideration transferred was $637 million, which includes cash paid to Idrica, the remeasurement to fair value of our previously held equity interest, the fair value of the redeemable non-controlling interest, and the settlement of a preexisting contractual relationship between the Company and Idrica. This relationship related to a distribution agreement which the Company had previously recognized in other non-current assets.
The acquisition-date fair value of the consideration consisted of the following:
| | | | | |
| (in millions) | Fair Value of Purchase Consideration |
| Cash paid | $ | 154 | |
| Fair value of previously held equity interest | 193 | |
Fair value of redeemable non-controlling interest | 237 | |
| Settlement of preexisting relationship | 53 | |
| Total | $ | 637 | |
The Company remeasured its previously held 25.1% equity interest in Idrica immediately prior to the completion of the acquisition to its estimated fair value of approximately $193 million. This fair value was derived by using the discounted cash flow method of the income approach, which considers future cash flows that are discounted to present value at a rate of return commensurate with the business and financial risks associated with the expected achievement of the projected cash flows. As a result of the remeasurement of its previously held equity interest, the Company recognized a gain of approximately $152 million in the fourth quarter of 2024. The gain reflects the excess
of the estimated fair value of $193 million for the Company’s previously held 25.1% equity interest over its carrying value of approximately $41 million.
The following table summarizes the acquisition date fair value of net tangible and intangible assets acquired, net of liabilities assumed from Idrica:
| | | | | | |
| (in millions) | Fair Value | |
| Cash and cash equivalents | $ | 4 | | |
| Receivables | 5 | | |
| Prepaid and other current assets | 7 | | |
| Goodwill | 520 | | |
| Other intangible assets, net | 165 | | |
| Other non-current assets | 15 | | |
| Accounts payable | (8) | | |
| Accrued and other current liabilities | (5) | | |
| Short term borrowings and current maturities of long-term debt | (16) | | |
| Long term debt | (7) | | |
| | |
| Deferred income tax liabilities | (40) | | |
| Other non-current accrued liabilities | (3) | | |
| | |
| | |
| Total | $ | 637 | | |
The above fair values of assets acquired and liabilities assumed were determined using the income and cost approaches.
Our revenue and net loss attributable to the Idrica acquisition for the years ended December 31, 2025 and 2024 were not material. The $520 million of goodwill recognized, which is not deductible for U.S. income tax purposes, is primarily attributable to costs and revenue synergies and economies of scale expected from combining the operations of Idrica with Xylem.
Identifiable Intangible Assets Acquired
The following table summarizes key information underlying identifiable intangible assets related to the Idrica acquisition:
| | | | | | | | |
| (in millions) | Useful Life (in years)(a) | Fair Value (in millions) |
| Customer Relationships | 24 | $ | 28 | |
| Backlog | 9 | 2 | |
| Technology | 7 | 132 | |
| Trade Name | 10 | 2 | |
| Intangible Assets Under Construction | N/A | 1 | |
| Total | 10 | $ | 165 | |
(a)Useful life approximates weighted average useful life.
•The fair value of Idrica’s identifiable intangible assets were determined using a combination of the income and cost approaches. The fair value measurements were primarily based on significant inputs that are not observable in the market and thus, represent a Level 3 measurement of the fair value hierarchy as defined in ASC 820, Fair Value Measurements. Intangible assets consisting of the customer relationships, backlog, and trade name were valued using the multi-period excess earnings method (“MEEM”) or the relief from royalty (“RFR”) method, both of which are forms of the income approach. The intangible asset related to Idrica’s developed technology was valued using the replacement cost approach.
•The customer and backlog intangible assets were valued using the MEEM. The MEEM is an approach where the net earnings attributable to the asset being measured are isolated from other “contributory assets” over the intangible asset’s remaining economic life.
•The trade name intangible asset was valued using the RFR method. The RFR method suggests that in lieu of ownership, the acquirer can obtain comparable rights to use the subject asset via a license from a hypothetical third-party owner. The asset’s fair value is the present value of license fees avoided by owning it (i.e., the royalty savings).
•The developed technology intangible asset was valued using the replacement cost approach. The replacement cost approach is a valuation method that relies on estimating the replacement costs of assets based on the principle that an asset would not be purchased for a price higher than the cost to replace it with an asset of comparable utility.
Pro forma results of operations have not been included, as the acquisition of Idrica was not material to our results of operations for any periods presented.
Heusser
On December 5, 2024, we acquired all issued and outstanding shares of Heusser Water Solutions AG ("Heusser"), a leading distributor and provider of advanced pumping systems and treatment solutions in Switzerland, for $40 million ($35 million, net of cash received). Heusser, a privately-owned company headquartered in Cham, Switzerland, has approximately 90 employees. Our consolidated financial statements include Heusser's results of operations prospectively from December 5, 2024 primarily within the Water Infrastructure segment.
Note 4. Revenue
Disaggregation of Revenue
The following table illustrates the sources of revenue:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Revenue from contracts with customers | $ | 8,720 | | | $ | 8,273 | | | $ | 6,963 | |
| Lease Revenue | 315 | | | 289 | | | 401 | |
| Total | $ | 9,035 | | | $ | 8,562 | | | $ | 7,364 | |
The following table reflects revenue from contracts with customers by application: | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, | | |
| (in millions) | 2025 | | 2024 | | 2023 | | |
| Water Infrastructure | | | | | | | |
| Transport | $ | 1,556 | | | $ | 1,496 | | | $ | 1,421 | | | |
| Treatment | 1,080 | | | 1,057 | | | 795 | | | |
| | | | | | | |
| Applied Water | | | | | | | |
| Building Solutions | 1,037 | | | 997 | | | 1,025 | | | |
| Industrial Water | 812 | | | 796 | | | 828 | | | |
| | | | | | | |
| Measurement and Control Solutions | | | | | | | |
| Smart Metering and Other | 1,726 | | | 1,519 | | | 1,253 | | | |
| Analytics | 360 | | | 352 | | | 358 | | | |
| | | | | | | |
| Water Solutions and Services | | | | | | | |
Capital and Other | 1,144 | | | 1,081 | | | 804 | | | |
Services | 1,005 | | | 975 | | | 479 | | | |
| | | | | | | |
| Total | $ | 8,720 | | | $ | 8,273 | | | $ | 6,963 | | | |
The following table reflects revenue from contracts with customers by geographical region:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Water Infrastructure | | | | | |
| United States | $ | 1,005 | | | $ | 891 | | | $ | 744 | |
| Western Europe | 937 | | | 914 | | | 822 | |
| Emerging Markets (a) | 477 | | | 526 | | | 458 | |
| Other | 217 | | | 222 | | | 192 | |
| | | | | |
| Applied Water | | | | | |
| United States | 1,018 | | | 942 | | | 970 | |
| Western Europe | 412 | | | 398 | | | 401 | |
| Emerging Markets (a) | 286 | | | 321 | | | 342 | |
| Other | 133 | | | 132 | | | 140 | |
| | | | | |
| Measurement and Control Solutions | | | | | |
| United States | 1,373 | | | 1,267 | | | 1,042 | |
| Western Europe | 342 | | | 282 | | | 282 | |
| Emerging Markets (a) | 197 | | | 190 | | | 193 | |
| Other | 174 | | | 132 | | | 94 | |
| | | | | |
| Water Solutions and Services | | | | | |
| United States | 1,597 | | | 1,570 | | | 916 | |
| Western Europe | 101 | | | 101 | | | 105 | |
| Emerging Markets (a) | 235 | | | 213 | | | 142 | |
| Other | 216 | | | 172 | | | 120 | |
| | | | | |
| Total | $ | 8,720 | | | $ | 8,273 | | | $ | 6,963 | |
(a)Emerging Markets includes results from the following regions: Eastern Europe, the Middle East and Africa, Latin America and Asia Pacific (excluding Japan, Australia and New Zealand, which are presented in "Other")
Contract Balances
We receive payments from customers based on a billing schedule as established in our contracts. Contract assets relate to costs incurred to perform in advance of scheduled billings. Contract liabilities relate to payments received in advance of performance under the contracts. Changes in contract assets and liabilities are due to our performance under the contract.
The table below provides contract assets, contract liabilities, and significant changes in contract assets and liabilities:
| | | | | | | | | | | | |
| (in millions) | Contract Assets (a) | Contract Liabilities (b) | | | | |
| Balance at 1/1/2024 | $ | 263 | | $ | 315 | | | | | |
| | | | | | |
| Additions, net | 265 | | 265 | | | | | |
| Revenue recognized from opening balance | — | | (247) | | | | | |
| Billings transferred to accounts receivable | (227) | | — | | | | | |
| Foreign currency and other | 2 | | (11) | | | | | |
| Balance at 1/1/2025 | $ | 303 | | $ | 322 | | | | | |
| | | | | | |
| Additions, net | 382 | | 251 | | | | | |
| Revenue recognized from opening balance | — | | (280) | | | | | |
| Billings transferred to accounts receivable | (185) | | — | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| Foreign currency and other | 10 | | (7) | | | | | |
| Balance at 12/31/2025 | $ | 510 | | $ | 286 | | | | | |
(a)Contract assets are included in either receivables or other non-current assets on the Consolidated Balance Sheets.
(b)Contract liabilities are included in either accrued and other current liabilities or other non-current liabilities on the Consolidated Balance Sheets.
Performance obligations
Delivery schedules vary from customer to customer based upon their requirements. Typically, large projects require longer lead production cycles and delays can occur from time to time. As of December 31, 2025, the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied for contracts with performance obligations, amount to $1,929 million. The Company elects to apply the practical expedient to exclude from this disclosure revenue related to performance obligations that are part of a contract whose original expected duration is less than one year.
Note 5. Restructuring and Asset Impairment Charges
From time to time, the Company will incur costs related to restructuring actions in order to optimize our cost base and more strategically position itself. During 2025, we incurred restructuring costs of $95 million. These charges were primarily related to actions taken to further streamline our organization through simplification efforts to strengthen our competitive positioning and our ability to better serve our customers.
During 2024, we incurred restructuring costs of $55 million. The charges incurred primarily related to strengthening our competitive positioning and the integration of Evoqua Water Technologies Corp. ("Evoqua").
During 2023, we incurred restructuring costs of $72 million. Approximately $27 million of the charges related to share-based compensation expense due to acceleration clauses in Evoqua's equity compensation agreements. Approximately $45 million of the charges represented the reduction of headcount related to the integration of Evoqua and other charges related to our efforts to reposition our businesses to optimize our cost structure, improve our operational efficiency and effectiveness, strengthen our competitive positioning and better serve our customers. The charges were incurred across all of our segments.
The following table presents the components of restructuring expense and asset impairment charges incurred during each of the previous three years: | | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| (in millions) | | 2025 | | 2024 | | 2023 |
| By component: | | | | | | |
| Severance and other charges | | $ | 92 | | | $ | 41 | | | $ | 70 | |
| | | | | | |
| Asset impairment | | 5 | | | 19 | | | 3 | |
| | | | | | |
| Reversal of restructuring accruals | | (2) | | | (5) | | | (1) | |
| Total restructuring costs | | 95 | | | 55 | | | 72 | |
| Asset impairment charges | | 8 | | | 7 | | | 4 | |
| Total restructuring and asset impairment charges | | $ | 103 | | | $ | 62 | | | $ | 76 | |
| | | | | | |
| By segment: | | | | | | |
| Water Infrastructure | | $ | 57 | | | $ | 23 | | | $ | 13 | |
| Applied Water | | 23 | | | 6 | | | 7 | |
| Measurement and Control Solutions | | 12 | | | 2 | | | 14 | |
| Water Solutions and Services | | 9 | | | 29 | | | 7 | |
| Corporate and Other | | 2 | | | 2 | | | 35 | |
| | | | | | |
Restructuring
The following table displays a roll-forward of the restructuring accruals, presented on our Consolidated Balance Sheets within "accrued and other current liabilities" and "other non-current accrued liabilities," for the years ended December 31, 2025 and 2024: | | | | | | | | | | | | | | |
| (in millions) | | 2025 | | 2024 |
| Restructuring accruals - January 1 | | $ | 25 | | | $ | 24 | |
| Restructuring costs | | 95 | | | 55 | |
| Cash payments | | (82) | | | (32) | |
| Asset impairment | | (5) | | | (19) | |
| Share based compensation expense included within AOCL | | — | | | (2) | |
| Foreign currency and other | | 1 | | | (1) | |
| Restructuring accruals - December 31 | | $ | 34 | | | $ | 25 | |
| | | | |
| By segment: | | | | |
| Water Infrastructure | | $ | 9 | | | $ | 4 | |
| Applied Water | | 1 | | | 3 | |
| Measurement and Control Solutions | | 4 | | | 3 | |
| Water Solutions and Services | | 3 | | | 4 | |
Centralized support facilities (a) | | 17 | | | 9 | |
| Corporate and other | | — | | | 2 | |
(a) Centralized support facilities consist primarily of support functions, including selling and marketing organizations, that incurred restructuring expense which was allocated to the segments. However, the liabilities associated with restructuring expense were not allocated to the segments.
The following table presents the total costs expected to be incurred, the amount incurred in the period, and the cumulative costs incurred to date for our 2025, 2024 and 2023 restructuring actions:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | | Water Infrastructure | | Applied Water | | Measurement and Control Solutions | | Water Solutions and Services | | Corporate | | Total |
| Actions Commenced in 2025: | | | | | | | | | | | | |
| Total expected costs | | $ | 75 | | | $ | 30 | | | $ | 17 | | | $ | 11 | | | $ | 9 | | | $ | 142 | |
| Costs incurred during 2025 | | 55 | | | 23 | | | 9 | | | 6 | | | — | | | 93 | |
| Total expected costs remaining | | $ | 20 | | | $ | 7 | | | $ | 8 | | | $ | 5 | | | $ | 9 | | | $ | 49 | |
| | | | | | | | | | | | |
| Actions Commenced in 2024: | | | | | | | | | | | | |
| Total expected costs | | $ | 15 | | | $ | 5 | | | $ | 1 | | | $ | 28 | | | $ | 1 | | | $ | 50 | |
| Costs incurred during 2024 | | 14 | | | 5 | | | 1 | | | 28 | | | 1 | | | 49 | |
| Costs incurred during 2025 | | 1 | | | — | | | — | | | — | | | — | | | 1 | |
| Total expected costs remaining | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | |
| | | | | | | | | | | | |
| Actions Commenced in 2023: | | | | | | | | | | | | |
| Total expected costs | | $ | 19 | | | $ | 7 | | | $ | 12 | | | $ | 8 | | | $ | 35 | | | $ | 81 | |
| Costs incurred during 2023 | | 13 | | | 6 | | | 10 | | | 7 | | | 35 | | | 71 | |
| Costs incurred during 2024 | | 6 | | | 1 | | | (2) | | | 1 | | | — | | | 6 | |
| Costs incurred during 2025 | | — | | | — | | | 1 | | | — | | | — | | | 1 | |
| Total expected costs remaining | | $ | — | | | $ | — | | | $ | 3 | | | $ | — | | | $ | — | | | $ | 3 | |
The actions commenced in 2025 consist primarily of severance. During 2025, the Company also recorded ROU asset and fixed asset impairment charges of $3 million within our Water Infrastructure segment and $2 million within our Measurement and Control Solutions segment due to these restructuring actions, which are expected to continue through the end of 2026.
The actions commenced in 2024 consist primarily of severance charges. During 2024, as a result of these restructuring actions, the Company also recorded $16 million in impairment charges primarily related to customer relationships and trademarks and $3 million in fixed asset impairment charges within our Water Solutions and Services segment. Refer to Note 12, "Goodwill and Other Intangible Assets," for additional information on the impairment of intangible assets. These actions were substantially completed in 2025.
The actions commenced in 2023 consist primarily of severance charges. We also recorded fixed asset impairment charges of $3 million within our Applied Water segment. The actions within Measurement and Control Solutions are expected to continue through the end of 2027.
During 2023, we also incurred charges of $1 million within the Applied Water segment, related to actions commenced prior to 2023.
Asset Impairment
During 2025, we recognized $1 million, $2 million, $3 million, and $2 million of impairment charges for internally developed software and software assets, respectively, across our Water Infrastructure, Measurement and Control Solutions, Water Solutions and Services segments, as well as within Corporate and other.
During 2024, we recognized an impairment charge of $3 million and $3 million related to certain leases and leasehold improvements within our Measurement and Control Solutions and Water Infrastructure segments, respectively. We also recognized $1 million impairment charge for internally developed software within Corporate and other.
During 2023, we recorded impairment charges of $3 million for internally developed in-process software and $1 million for certain fixed assets within our Measurement and Control Solutions segment.
Note 6. Other Non-Operating Income, Net
The components of other non-operating income, net are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Interest income | $ | 27 | | | $ | 28 | | | $ | 28 | |
| Pension and other postretirement benefit expense | (7) | | | (4) | | | (3) | |
| Income (expense) from equity method investments | 2 | | | (4) | | | — | |
| Other (expense) income – net | (4) | | | (4) | | | 8 | |
| Total other non-operating income, net | $ | 18 | | | $ | 16 | | | $ | 33 | |
Note 7. Income Taxes
The source of pre-tax income and the components of income tax expense are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Income components: | | | | | |
| Domestic | $ | 695 | | | $ | 471 | | | $ | 123 | |
| Foreign | 486 | | | 616 | | | 512 | |
| Total pre-tax income | $ | 1,181 | | | $ | 1,087 | | | $ | 635 | |
| Income tax expense (income) components: | | | | | |
| Current: | | | | | |
| Domestic – federal | $ | 122 | | | $ | 108 | | | $ | (4) | |
| Domestic – state and local | 36 | | | 35 | | | 23 | |
| Foreign | 108 | | | 90 | | | 86 | |
| Total Current | $ | 266 | | | $ | 233 | | | $ | 105 | |
| Deferred: | | | | | |
| Domestic – federal | $ | (30) | | | $ | (38) | | | $ | (49) | |
| Domestic – state and local | (7) | | | (11) | | | (8) | |
| Foreign | 2 | | | 13 | | | (22) | |
| Total Deferred | (35) | | | (36) | | | (79) | |
| Total income tax provision | $ | (231) | | | $ | (197) | | | $ | (26) | |
| Effective income tax rate | 19.5 | % | | 18.1 | % | | 4.1 | % |
Reconciliations between taxes at the U.S. federal statutory tax rate and taxes at our effective income tax rate on earnings before income taxes are as follows:
| | | | | | | | | | | | | | | | |
| Year Ended December 31, | | | | | | |
| (in millions) | 2025 | | | | |
| U.S. federal statutory tax rate | $ | 248 | | 21.0 | % | | | | | | |
| State & local income tax, net of federal benefit (NOFB) | 21 | | 1.8 | % | (a) | | | | | |
| Foreign tax effects | | | | | | | | |
| Switzerland | | | | | | | | |
| Statutory tax rate difference between Switzerland and U.S. | (28) | | (2.4) | % | | | | | | |
| Effect of cantonal and communal income taxes | 9 | | 0.7 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Other adjustments | (3) | | (0.3) | % | | | | | | |
| Luxembourg | | | | | | | | |
| | | | | | | | |
| Changes in valuation allowances | 17 | | 1.5 | % | | | | | | |
Tax effect of internal reorganization | (18) | | (1.5) | % | | | | | | |
| | | | | | | | |
| Other adjustments | 3 | | 0.3 | % | | | | | | |
| Malta | | | | | | | | |
| Notional interest deduction | (19) | | (1.6) | % | | | | | | |
Notional interest carryforward | (36) | | (3.1) | % | | | | | | |
Changes in valuation allowances | 36 | | 3.1 | % | | | | | | |
| Other adjustments | 3 | | 0.2 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Other foreign jurisdictions | 26 | | 2.2 | % | | | | | | |
| | | | | | | | |
| Effect of cross-border tax laws | | | | | | | | |
| | | | | | | | |
| | | | | | | | |
Foreign exchange on repatriations | 13 | | 1.1 | % | | | | | | |
| Other adjustments | (5) | | (0.4) | % | | | | | | |
| Tax credits | (10) | | (0.9) | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Changes in valuation allowances | 2 | | 0.2 | % | | | | | | |
| Nontaxable or nondeductible items | 4 | | 0.3 | % | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Changes in unrecognized tax benefits | 4 | | 0.3 | % | | | | | | |
| Other adjustments | | | | | | | | |
Deferred tax effects of internal reorganization | (42) | | (3.6) | % | (b) | | | | | |
| Other adjustments | 6 | | 0.6 | % | | | | | | |
| Effective income tax rate | $ | 231 | | 19.5 | % | | | | | | |
(a) State and local taxes in California, Florida, Texas, Minnesota, New York, and Pennsylvania made up the majority (greater than 50 percent) of the tax effect in this category
(b) $42 million benefit reflects a one-time deferred tax benefit recorded in connection with an internal reorganization executed during the year.
| | | | | | | | | | | |
| Year Ended December 31, |
| 2024 | | 2023 |
| Tax provision at U.S. statutory rate | 21.0 | % | | 21.0 | % |
| Increase (decrease) in tax rate resulting from: | | | |
| State income taxes | 1.8 | | | 1.7 | |
| Uncertain tax positions | — | | | (9.9) | |
| U.S. tax on foreign earnings | 1.2 | | | 2.5 | |
| Tax incentives | (1.3) | | | (2.6) | |
| Valuation allowance | 1.7 | | | (5.8) | |
| Gain on remeasurement of previously held equity interest | (3.0) | | | — | |
| Rate change | (0.6) | | | (2.0) | |
| Federal R&D tax credit | (0.6) | | | (0.5) | |
| Stock compensation | (0.7) | | | (0.6) | |
| U.S. foreign derived intangible income tax benefit | (0.6) | | | (0.7) | |
| Tax on distribution of foreign earnings | 1.0 | | | — | |
| Non-deductible compensation | 0.4 | | | 1.2 | |
| Other tax credits | (0.2) | | | (1.8) | |
| Other – net | (2.0) | | | 1.6 | |
| Effective income tax rate | 18.1 | % | | 4.1 | % |
Income taxes paid (net of refunds) for the years ended December 31 are as follows:
| | | | | | | | | | | | | | | | | | | | |
| (in millions) | Year Ended December 31, | |
| Jurisdiction | 2025 | | 2024 | | 2023 | |
| Federal | $ | 135 | | | $ | 79 | | | $ | 114 | | |
| State & Local | 37 | | | 32 | | | 29 | | |
| Foreign | | | | | | |
| Netherlands | — | | (a) | 14 | | | — | | (a) |
| Switzerland | 14 | | 24 | | 11 | |
| United Kingdom | — | | (a) | 12 | | — | | (a) |
| All other foreign jurisdictions | 81 | | | 58 | | | 57 | | |
| Total Taxes Paid | $ | 267 | | | $ | 219 | | | $ | 211 | | |
(a) Amounts for these jurisdictions in 2025 and 2023 fall below the 5% threshold and are not required to be disclosed under ASU 2023-09.
Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities, applying enacted tax rates in effect for the year in which we expect the differences will reverse.
The following is a summary of the components of the net deferred tax assets and liabilities recognized in the Consolidated Balance Sheets:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Deferred tax assets: | | | |
| Employee benefits | $ | 58 | | | $ | 77 | |
| Accrued expenses | 49 | | | 52 | |
| Loss and other tax credit carryforwards | 333 | | | 236 | |
| R&D capitalization | 68 | | | 57 | |
| Inventory | 4 | | | 3 | |
| | | |
| Lease Liabilities | 95 | | | 73 | |
| | | |
| Hedging instruments | 77 | | | 2 | |
| Other | 31 | | | 11 | |
| Total deferred tax assets | 715 | | | 511 | |
| Valuation allowance | (290) | | | (189) | |
| Net deferred tax asset | $ | 425 | | | $ | 322 | |
| Deferred tax liabilities: | | | |
| Intangibles | $ | 482 | | | $ | 501 | |
| Investment in foreign subsidiaries | 10 | | | 6 | |
| Property, plant and equipment | 103 | | | 105 | |
| Lease right-of-use assets | 91 | | | 70 | |
| Hedging Instruments | 1 | | | 7 | |
| Other | 2 | | | 5 | |
| Total deferred tax liabilities | $ | 689 | | | $ | 694 | |
Management assesses all available positive and negative evidence, including prudent and feasible tax planning strategies, and estimates if sufficient future taxable income will be generated to realize existing deferred tax assets. On the basis of this evaluation, as of December 31, 2025, a valuation allowance of $290 million has been established to reduce the deferred income tax asset related to certain U.S. and foreign net operating losses and U.S. and foreign capital loss carryforwards.
A reconciliation of the change in valuation allowance on deferred tax assets is as follows:
| | | | | | | | | | | | | | | | | |
| (in millions) | 2025 | | 2024 | | 2023 |
| Valuation allowance — January 1 | $ | 189 | | | $ | 179 | | | $ | 204 | |
| Change in assessment (a) | (4) | | | — | | | (47) | |
| Current year operations | 57 | | | 22 | | | 12 | |
| Other comprehensive income | 3 | | | 1 | | | 1 | |
| Foreign currency and other (b) | 45 | | | (12) | | | 5 | |
| Acquisitions | — | | | (1) | | | 4 | |
| Valuation allowance — December 31 | $ | 290 | | | $ | 189 | | | $ | 179 | |
(a) Decrease in valuation allowance in 2025 and 2023 is primarily attributable to changes in realization on deferred tax assets in various foreign jurisdictions.
(b) Increase in 2025 and decrease in 2024 in valuation allowance is primarily attributed to foreign exchange movement impacting foreign balances.
Deferred taxes are classified in the Consolidated Balance Sheets as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| | | |
| Non-current assets | $ | 141 | | | $ | 125 | |
| | | |
| Non-current liabilities | (405) | | | (497) | |
| Total net deferred tax liabilities | $ | (264) | | | $ | (372) | |
Tax attributes available to reduce future taxable income begin to expire as follows:
| | | | | | | | | | | |
| (in millions) | December 31, 2025 | | First Year of Expiration |
| U.S. net operating loss | $ | 2 | | | December 31, 2026 |
| U.S. tax credits | 7 | | | December 31, 2032 |
| State net operating loss | 99 | | | December 31, 2026 |
| State excess interest expense | 26 | | | Indefinite |
| | | |
| Foreign net operating loss | 1,359 | | | December 31, 2026 |
| Foreign tax credits | 5 | | | December 31, 2030 |
Unrecognized Tax Benefits
We recognize tax benefits from uncertain tax positions only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities or upon the completion of the litigation process, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate resolution.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| | | | | | | | | | | | | | | | | |
| (in millions) | 2025 | | 2024 | | 2023 |
| Unrecognized tax benefits — January 1 | $ | 37 | | | $ | 35 | | | $ | 102 | |
| Gross Increases - Current year tax positions | 6 | | | 3 | | | 2 | |
| Gross Increases - Prior year tax positions | 6 | | | 1 | | | 4 | |
| Gross Decreases - Prior year tax positions | (1) | | | (1) | | | (75) | |
| Acquisitions | — | | | 4 | | | 2 | |
| Settlements | — | | | (2) | | | — | |
| Lapse of Statute of Limitations | — | | | (3) | | | — | |
| Currency Translation Adjustment | 1 | | | — | | | — | |
| Unrecognized tax benefits — December 31 | $ | 49 | | | $ | 37 | | | $ | 35 | |
The amount of unrecognized tax benefits at December 31, 2025, which, if ultimately recognized, will reduce our effective tax rate, is $49 million. Changes in tax laws, regulations, administrative practices, principles, and interpretations may impact our unrecognized tax benefits. The timing of the resolution of income tax controversies is highly uncertain, and the amounts ultimately paid, if any, upon resolution of the issues raised by the taxing authorities may differ from the amounts accrued. It is reasonably possible that within the next twelve months we will receive additional assessments by various tax authorities or possibly reach resolution of income tax controversies in one or more jurisdictions. These assessments or settlements could result in changes to our unrecognized tax benefits related to positions on prior years’ tax filings. The actual amount of any change could vary significantly depending on the ultimate timing and nature of any settlements. We cannot currently provide an estimate of the range of possible outcomes.
We classify interest relating to unrecognized tax benefits as a component of other non-operating (expense) income, net and tax penalties as a component of income tax expense in our Consolidated Income Statements. The amount of accrued interest relating to unrecognized tax benefits as of December 31, 2025 and 2024 was $9 million and $7 million, respectively.
During 2019, Xylem’s Swedish subsidiary received a tax assessment from the Swedish Tax Agency (the "STA") for the 2013 tax year related to the tax treatment of an intercompany transfer of certain intellectual property that was made in connection with a reorganization of our European businesses. Xylem filed an appeal with the Administrative Court of Växjö, which rendered a decision adverse to Xylem in June 2022 for SEK837 million (approximately $91 million USD), consisting of the full tax assessment amount plus penalties and interest. Xylem has appealed this decision with the intermediate appellate court, the Administrative Court of Appeal, and on May 15, 2024, that court rendered a decision in favor of Xylem and also remanded an issue to the trial court for resolution. In December 2025, the trial court issued a ruling on the remanded issue in Xylem's favor. The STA has appealed this ruling to the Administrative Court of Appeal. Management, in consultation with external legal advisors, continues to believe it is more likely than not that Xylem will prevail on the proposed assessment and will continue to vigorously defend our position through this litigation. There can be no assurance that the final determination by the authorities will not be materially different than our position. As of December 31, 2025, we have not recorded any unrecognized tax benefits related to this uncertain tax position.
The following table summarizes our earliest open tax years by major jurisdiction:
| | | | | | | | |
| Jurisdiction | | Earliest Open Year |
| Italy | | 2020 |
| Luxembourg | | 2021 |
| Sweden | | 2013 |
| Germany | | 2016 |
| United Kingdom | | 2021 |
| United States | | 2017 |
| Switzerland | | 2019 |
Note 8. Earnings Per Share
The following is a reconciliation of the shares used in calculating basic and diluted EPS:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| Net income attributable to Xylem (in millions) | $ | 957 | | | $ | 890 | | | $ | 609 | |
| Shares (in thousands): | | | | | |
| Weighted average common shares outstanding | 243,345 | | | 242,557 | | | 216,982 | |
| Add: Participating securities (a) | 21 | | | 26 | | | 30 | |
| Weighted average common shares outstanding — Basic | 243,366 | | | 242,583 | | | 217,012 | |
| Plus incremental shares from assumed conversions: (b) | | | | | |
| Dilutive effect of stock options | 345 | | | 526 | | | 768 | |
| Dilutive effect of restricted stock units and performance share units | 283 | | | 412 | | | 400 | |
| Weighted average common shares outstanding — Diluted | 243,994 | | | 243,521 | | | 218,180 | |
| Basic earnings per share | $ | 3.93 | | | $ | 3.67 | | | $ | 2.81 | |
| Diluted earnings per share | $ | 3.92 | | | $ | 3.65 | | | $ | 2.79 | |
(a)Restricted stock units containing rights to non-forfeitable dividends that participate in undistributed earnings with common shareholders are considered participating securities for purposes of computing EPS.
(b)Incremental shares from stock options, restricted stock units and performance share units are computed by the treasury stock method. The weighted average shares listed below were not included in the computation of diluted earnings per share because to do so would have been anti-dilutive for the periods presented or were otherwise excluded under the treasury stock method. The treasury stock method calculates dilution assuming the exercise of all in-the-money options and vesting of restricted stock units and performance share units, reduced by the repurchase of shares with the proceeds from the assumed exercises and unrecognized compensation expense for outstanding awards. Performance share units are included in the treasury stock calculation of diluted earnings per share based upon achievement of underlying performance and market conditions at the end of the reporting period, as applicable. See Note 17, "Share-Based Compensation Plans," for further detail on the performance share units.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in thousands) | 2025 | | 2024 | | 2023 |
| Stock options | 908 | | | 951 | | | 1,703 | |
| Restricted stock units | 350 | | | 404 | | | 566 | |
| Performance share units | 160 | | | 262 | | | 289 | |
Note 9. Inventories
The components of total inventories are summarized as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Finished goods | $ | 342 | | | $ | 341 | |
| Work in process | 100 | | | 100 | |
| Raw materials | 541 | | | 555 | |
| Total inventories | $ | 983 | | | $ | 996 | |
Note 10. Property, Plant and Equipment
The components of total property, plant and equipment, net are as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Land, buildings and improvements | $ | 512 | | | $ | 477 | |
| Machinery and equipment | 1,529 | | | 1,342 | |
| Equipment held for lease or rental | 344 | | | 328 | |
| Furniture and fixtures | 162 | | | 150 | |
| Construction work in progress | 175 | | | 228 | |
| Other | 75 | | | 61 | |
| Total property, plant and equipment, gross | 2,797 | | | 2,586 | |
| Less accumulated depreciation | 1,638 | | | 1,434 | |
| Total property, plant and equipment, net | $ | 1,159 | | | $ | 1,152 | |
Depreciation expense related to property, plant and equipment was $231 million, $230 million, and $177 million for 2025, 2024, and 2023, respectively.
Note 11. Leases
Leasing Arrangements
We lease certain offices, manufacturing buildings, transportation equipment, machinery, computers and other equipment. Our most significant lease liabilities relate to real estate leases. These leases include renewal, termination or purchase options, and we have assessed these to determine whether it is reasonably certain for us to exercise any of the previously mentioned options. All periods relating to options that are reasonably certain to be exercised have been included in the lease term of the respective leases.
We evaluated whether any events or conditions during the 12-month period ended December 31, 2025 to indicate that a reassessment or re-measurement of our existing leases was required. As a result, we recognized a ROU asset impairment of approximately $1 million for the 12-month period ended December 31, 2025 due to strategic decisions to close certain locations and to impair office locations that were no longer being used as intended or weren't able to be subleased.
Our current operating lease liabilities of $87 million and $82 million are included in "accrued and other current liabilities" as of December 31, 2025 and 2024, respectively. Our non-current operating lease liabilities of $321 million and $242 million are included in "Other non-current accrued liabilities" as of December 31, 2025 and 2024, respectively. Our net operating lease ROU asset balances of $391 million and $309 million are included in "other non-current assets" as of December 31, 2025 and 2024, respectively.
Our current finance lease liabilities of $34 million and $27 million are included in accrued and other current liabilities as of December 31, 2025 and 2024, respectively. Our non-current finance lease liabilities of $91 million and $76 million are included in "other non-current accrued liabilities" as of December 31, 2025 and 2024, respectively. Our net finance lease ROU asset balances of $118 million and $97 million are included in "other non-current assets" as of December 31, 2025 and 2024, respectively.
| | | | | | | | | | | | |
| Year Ended December 31, | |
| (in millions) | 2025 | 2024 | 2023 | |
| Lease cost | | | | |
| Finance lease cost: | | | | |
Depreciation of ROU assets | $ | 36 | | $ | 28 | | $ | 16 | | |
| Interest on lease liabilities | 6 | | 4 | | 2 | | |
| Operating lease cost | 111 | | 106 | | 96 | | |
| Short-term lease cost | 3 | | 3 | | 4 | | |
| Variable lease cost | 30 | | 30 | | 23 | | |
| Total lease cost | $ | 186 | | $ | 171 | | $ | 141 | | |
The supplemental cash flow information related to leases are as follows:
| | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | 2024 | 2023 |
| Cash paid for amounts included in the measurement of lease liabilities: | | | |
| Operating cash flows from finance leases | $ | 5 | | $ | 4 | | $ | 2 | |
| Operating cash flows from operating leases | $ | 108 | | $ | 103 | | $ | 92 | |
| Financing cash flows from finance leases | $ | 33 | | $ | 24 | | $ | 14 | |
| Right-of-use assets obtained in exchange for lease obligations: | | | |
| Finance leases | $ | 48 | | $ | 38 | | $ | 34 | |
| Operating leases | $ | 147 | | $ | 57 | | $ | 74 | |
Information relating to the lease term and discount rate are as follows:
| | | | | | | | | |
| Year Ended December 31, | |
| 2025 | 2024 | |
| Weighted-average remaining lease term (years) | | | |
| Operating leases | 7 Years | 5 Years | |
| Finance leases | 4 Years | 4 Years | |
| | | | |
| Weighted-average discount rate | | | |
| Operating leases | 4.0% | 3.5% | |
| Finance leases | 4.7% | 4.5% | |
As of December 31, 2025, the maturities of finance lease liabilities were as follows:
| | | | | | |
| (in millions) | | |
| 2026 | $ | 39 | | |
| 2027 | 35 | | |
| 2028 | 27 | | |
| 2029 | 20 | | |
| 2030 | 11 | | |
| Thereafter | 5 | | |
| Total lease payments | 137 | | |
| Less: Imputed interest | (12) | | |
| Total | $ | 125 | | |
As of December 31, 2025, the maturities of operating lease liabilities were as follows:
| | | | | | |
| (in millions) | | |
| 2026 | $ | 101 | | |
| 2027 | 86 | | |
| 2028 | 69 | | |
| 2029 | 50 | | |
| 2030 | 36 | | |
| Thereafter | 133 | | |
| Total lease payments | 475 | | |
| Less: Imputed interest | (67) | | |
| Total | $ | 408 | | |
Lessor arrangements
Our gross assets available for rent were $360 million and $328 million as of December 31, 2025 and 2024, respectively. The accumulated depreciation related to our gross assets was $221 million and $193 million as of December 31, 2025 and 2024, respectively. Depreciation expense for these assets was $42 million, $38 million and $58 million for the 12 month period ended December 31, 2025, 2024 and 2023, respectively. Total revenue from lease arrangements was $315 million, $289 million and $401 million for the years ended December 31, 2025, 2024 and 2023, respectively.
Note 12. Goodwill and Other Intangible Assets
As a result of the change in reportable segments disclosed in Note 1, "Summary of Significant Accounting Policies," goodwill was reallocated amongst segments. This reallocation and changes in the carrying value of goodwill by reportable segment during the years ended December 31, 2025 and 2024 are as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Water Infrastructure | | Applied Water | | Measurement and Control Solutions | | Water Solutions and Services | | Total |
| Balance as of December 31, 2023 | $ | 2,434 | | | $ | 895 | | | $ | 1,739 | | | $ | 2,519 | | | $ | 7,587 | |
| Reallocation | (287) | | | — | | | (64) | | | 351 | | | — | |
| Balance as of January 1, 2024 | 2,147 | | | 895 | | | 1,675 | | | 2,870 | | | 7,587 | |
| Activity in 2024 | | | | | | | | | |
| Acquisitions (a) | 15 | | | — | | | 521 | | | 1 | | | 537 | |
| | | | | | | | | |
| Foreign currency and other | (64) | | | (11) | | | (33) | | | (36) | | | (144) | |
| Balance as of December 31, 2024 | $ | 2,098 | | | $ | 884 | | | $ | 2,163 | | | $ | 2,835 | | | $ | 7,980 | |
| Activity in 2025 | | | | | | | | | |
| Acquisitions (a) | 76 | | | — | | | — | | | 38 | | | 114 | |
| Reclassification to assets held for sale (b) | — | | | — | | | (20) | | | — | | | (20) | |
| Foreign currency and other | 90 | | | 21 | | | 127 | | | 20 | | | 258 | |
| Balance as of December 31, 2025 | $ | 2,264 | | | $ | 905 | | | $ | 2,270 | | | $ | 2,893 | | | $ | 8,332 | |
(a) See Note 3, "Acquisitions and Divestitures," for additional information.
(b) Relates to reclassification of goodwill allocated for the International Metering Business divestiture. See Note 3, "Acquisitions and Divestitures," for additional information.
As of December 31, 2025 and 2024, goodwill included accumulated impairment losses of $206 million, within the Water Solutions and Services segment.
The Company has applied the acquisition method of accounting in accordance with ASC 805 and recognized assets acquired and liabilities assumed at their fair value as of the date of acquisition, with the excess purchase consideration recorded to goodwill. We have allocated goodwill to segments of the Company that are expected to benefit from the synergies of the acquisitions.
During the fourth quarter of 2025, we performed our annual impairment assessment and determined that the estimated fair values of our goodwill reporting units were in excess of each of their carrying values. However, future goodwill impairment tests could result in a charge to earnings. We will continue to evaluate goodwill on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.
During the second quarter of 2025, the Company modified its reporting unit structure in connection with changes in how management monitors and evaluates the business. Prior to this change, the Water Infrastructure segment consisted of a single reporting unit, and the Water Solutions and Services segment consisted of three reporting units: Integrated Solutions and Services, Dewatering, and Assessment Services. Following the reorganization, the Water Infrastructure segment is comprised of two reporting units—Transport and Treatment—and the Water Solutions and Services segment is comprised of two reporting units—Water Solutions and Services excluding Dewatering and Dewatering.
As a result of the change in reporting units, the Company reassigned goodwill to the affected reporting units using a relative fair value allocation methodology. The change in reporting units constituted a triggering event under ASC 350, "Intangibles—Goodwill and Other," requiring the Company to perform an interim goodwill impairment test for the impacted reporting units prior to the reassignment. No impairment was identified as a result of this testing.
Other Intangible Assets
Information regarding our other intangible assets is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2025 | | December 31, 2024 |
| (in millions) | Carrying Amount | | Accumulated Amortization | | Net Intangibles | | Carrying Amount | | Accumulated Amortization | | Net Intangibles |
| Customer and distributor relationships | $ | 2,180 | | | $ | (688) | | | $ | 1,492 | | | $ | 2,151 | | | $ | (576) | | | $ | 1,575 | |
| Proprietary technology and patents | 430 | | | (185) | | | 245 | | | 360 | | | (138) | | | 222 | |
| Trademarks | 183 | | | (126) | | | 57 | | | 182 | | | (107) | | | 75 | |
| Software (a) | 644 | | | (431) | | | 213 | | | 595 | | | (367) | | | 228 | |
| Other | 153 | | | (56) | | | 97 | | | 194 | | | (79) | | | 115 | |
| Indefinite-lived intangibles | 168 | | | — | | | 168 | | | 164 | | | — | | | 164 | |
| Other intangibles | $ | 3,758 | | | $ | (1,486) | | | $ | 2,272 | | | $ | 3,646 | | | $ | (1,267) | | | $ | 2,379 | |
(a)Includes capitalized software developed as a product or service offered directly to external customers. As of December 31, 2025 and 2024, we had net capitalized software used in sales and services to external customers of $175 million and $185 million, respectively.
We determined that no impairment of the indefinite-lived intangibles existed as of the measurement date of our impairment assessment in 2025. Future impairment tests could result in a charge to earnings. We will continue to evaluate the indefinite-lived intangible assets on an annual basis as of the beginning of our fourth quarter and whenever events and changes in circumstances indicate there may be a potential impairment.
During 2025, we recognized $1 million in impairment charges for internally developed software within our Water Infrastructure segment, $2 million within our Measurement and Control Solutions segment and $3 million within our Water Solutions and Services segment. We also recognized a $2 million impairment charge for software within Corporate and other.
During 2024, we recognized $13 million in impairment charges primarily related to customer relationships and trademarks due to restructuring actions within our Water Solutions and Services segment. We also recognized a $1 million impairment charge for internally developed software within Corporate and other.
During 2023, we recognized $3 million in impairment charges, primarily related to software within our Measurement and Control Solutions segment.
The asset impairment charges above were calculated using an income approach, which is considered a Level 3 input for fair value measurement.
Customer and distributor relationships, proprietary technology and patents, trademarks, software and other are amortized over weighted average lives of approximately 16 years, 8 years, 11 years, 10 years and 8 years, respectively.
Total amortization expense for intangible assets was $308 million, $304 million, and $243 million for 2025, 2024 and 2023, respectively.
Estimated amortization expense for each of the five succeeding years is as follows:
| | | | | |
| (in millions) | |
| 2026 | $ | 293 | |
| 2027 | 260 | |
| 2028 | 241 | |
| 2029 | 216 | |
| 2030 | 195 | |
| Thereafter | 899 | |
Note 13. Derivative Financial Instruments
Risk Management Objective of Using Derivatives
We are exposed to certain risks arising from both our business operations and economic conditions, and we principally manage our exposures to these risks through management of our core business activities. Certain of our foreign operations expose us to fluctuations of foreign interest rates and exchange rates that may impact revenue, expenses, cash receipts, cash payments, and the value of our stockholders' equity. We enter into derivative financial instruments to protect the value or fix the amount of certain cash flows in terms of the functional currency of the business unit with that exposure and reduce the volatility in stockholders' equity.
Cash Flow Hedges of Foreign Exchange Risk
We are exposed to fluctuations in various foreign currencies against our functional currencies. We use foreign currency derivatives, including currency forward agreements, to manage our exposure to fluctuations in the various exchange rates. Currency forward agreements involve fixing the foreign currency exchange rate for delivery of a specified amount of foreign currency on a specified date.
Certain business units with exposure to foreign currency exchange risks have designated certain currency forward agreements as cash flow hedges of forecasted intercompany inventory purchases and sales. Our principal currency exposures relate to the Euro, Swedish Krona, Canadian Dollar, Polish Zloty, British Pound and Australian Dollar. We had foreign exchange contracts with purchase notional amounts totaling $759 million and $657 million as of December 31, 2025 and 2024, respectively. As of December 31, 2025, our most significant foreign currency derivatives included contracts to sell U.S. Dollar and purchase Euro, purchase Swedish Krona and sell Euro, sell British Pound and purchase Euro, sell Canadian Dollar and purchase Euro, sell Canadian Dollar and purchase U.S. Dollar, purchase Polish Zloty and sell Euro, and sell Australian Dollar and purchase Euro. The purchased notional amounts associated with these currency derivatives are $275 million, $226 million, $119 million, $44 million, $37 million, $33 million, and $25 million, respectively. As of December 31, 2024, our most significant foreign currency derivatives included contracts to sell U.S. Dollar and purchase Euro, purchase Swedish Krona and sell Euro, sell British Pound and purchase Euro, sell Canadian Dollar and purchase Euro, sell Canadian Dollar and purchase U.S. Dollar, purchase Polish Zloty and sell Euro, and sell Australian Dollar and purchase Euro. The purchased notional amounts associated with these currency derivatives are $258 million, $169 million, $90 million, $42 million, $40 million, $34 million, and $24 million, respectively.
Hedges of Net Investments in Foreign Operations
We are exposed to changes in foreign currencies impacting our net investments held in foreign subsidiaries.
Cross-Currency Swaps
We have foreign currency exposure to fluctuations in the Euro-U.S. Dollar exchange rate due to our net investment in foreign operations. We use cross-currency swaps to partially mitigate the impact of the Euro currency rate changes on the Company’s Euro-denominated net investments. The Company’s cross-currency swaps are designated as net investment hedges. The total notional amount of derivative instruments designated as net investment hedges was $3,171 million and $2,181 million as of December 31, 2025 and 2024, respectively.
The table below presents the effect of our derivative financial instruments on the Consolidated Income Statements and Consolidated Statements of Comprehensive Income:
| | | | | | | | | | | | | | | | | | | | |
| | | Year Ended December 31, |
| (in millions) | | 2025 | | 2024 | | 2023 |
| Derivatives in Cash Flow Hedges | | | | | | |
| Foreign Exchange Contracts | | | | | | |
| Amount of gain/(loss) recognized in OCI/L | | $ | 35 | | | $ | (17) | | | $ | (2) | |
| Amount of (gain)/loss reclassified from OCI/L into Revenue | | (4) | | | 1 | | | 3 | |
| Amount of (gain)/loss reclassified from OCI/L into Cost of revenue | | (5) | | | 1 | | | 4 | |
| | | | | | |
| Derivatives in Net Investment Hedges | | | | | | |
| Cross-Currency Swaps | | | | | | |
| Amount of (loss)/gain recognized in OCI/L | | $ | (344) | | | $ | 62 | | | $ | (121) | |
| Amount of income recognized in Interest expense | | 42 | | | 32 | | | 30 | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
As of December 31, 2025, $9 million of net gain on cash flow hedges are expected to be reclassified into earnings in the next 12 months.
As of December 31, 2025, no gains or losses on the net investment hedges are expected to be reclassified into earnings over their duration.
The fair values of our derivative assets and liabilities are measured on a recurring basis using Level 2 inputs and are determined through the use of models that consider various assumptions including yield curves, time value and other measurements.
The fair values of our derivative contracts currently included in our hedging program were as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Derivatives designated as hedging instruments | | | |
| Assets | | | |
| Cash Flow Hedges | | | |
| Prepaid and other current assets | $ | 7 | | | $ | 3 | |
| Net Investment Hedges | | | |
| Other non-current assets | $ | — | | | $ | 50 | |
| Liabilities | | | |
| Cash Flow Hedges | | | |
| Accrued and other current liabilities | $ | (2) | | | $ | (15) | |
| Net Investment Hedges | | | |
| Other non-current accrued liabilities | $ | (317) | | | $ | (30) | |
Note 14. Current Liabilities
The components of total accrued and other current liabilities are as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Compensation and other employee-benefits | $ | 371 | | | $ | 409 | |
| Customer-related liabilities | 370 | | | 384 | |
| Accrued taxes | 207 | | | 201 | |
| Lease liabilities | 121 | | | 109 | |
| Accrued warranty costs | 43 | | | 43 | |
| Accrued restructuring liabilities | 34 | | | 25 | |
| Other accrued liabilities | 91 | | | 100 | |
| Total accrued and other current liabilities | $ | 1,237 | | | $ | 1,271 | |
The Company facilitates the opportunity for suppliers to participate in voluntary supply chain financing programs with third-party financial institutions. Xylem agrees on commercial terms, including payment terms, with suppliers regardless of program participation. The Company does not determine the terms or conditions of the arrangement between suppliers and the third-party financial institutions. Participating suppliers are paid directly by the third-party financial institution. Xylem pays the third-party financial institution the stated amount of confirmed invoices from its designated suppliers at the original invoice amount on the original maturity dates of the invoices, ranging from 45-180 days. Xylem does not pay fees related to these programs. Xylem or the third-party financial institutions may terminate the agreements upon at least 30 days notice. The total outstanding balance presented within "Accounts payable" on our Condensed Consolidated Balance Sheets under these programs is $244 million and $250 million as of December 31, 2025 and 2024, respectively.
The table below provides changes in the confirmed obligations outstanding related to our supplier financing programs over the year December 31, 2025:
| | | | | | |
| (in millions) | 2025 | |
| Confirmed obligations outstanding – January 1 | $ | 250 | | |
| Invoices confirmed | 1,042 | | |
| Confirmed invoices paid | (1,053) | | |
| Foreign currency and other | 5 | | |
| Confirmed obligations outstanding – December 31 | $ | 244 | | |
Note 15. Credit Facilities and Debt
Total debt outstanding is summarized as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| | | |
| | | |
3.250% Senior Notes due 2026 (a) | $ | 500 | | | $ | 500 | |
1.950% Senior Notes due 2028 (a) | 500 | | | 500 | |
2.250% Senior Notes due 2031 (a) | 500 | | | 500 | |
4.375% Senior Notes due 2046 (a) | 400 | | | 400 | |
| Equipment Financing due 2025 to 2032 | 27 | | | 106 | |
| | | |
| | | |
| | | |
| | | |
| Other | 27 | | | 25 | |
| Debt issuance costs and unamortized discount (b) | (12) | | | (15) | |
| | | |
| Total debt | $ | 1,942 | | | $ | 2,016 | |
| Less: short-term borrowings and current maturities of long-term debt | 534 | | | 38 | |
| Total long-term debt | $ | 1,408 | | | $ | 1,978 | |
(a)The fair value of our Senior Notes was determined using quoted prices in active markets for identical securities, which are considered Level 1 inputs. The fair value of our Senior Notes due 2026 was $497 million and $488 million as of December 31, 2025 and 2024, respectively. The fair value of our Senior Notes due 2028 was $480 million and $459 million as of December 31, 2025 and 2024, respectively. The fair value of our Senior Notes due 2031 was $454 million and $427 million as of December 31, 2025 and 2024 respectively. The fair value of our Senior Notes due 2046 was $340 million and $327 million as of December 31, 2025 and 2024, respectively.
(b)The debt issuance costs and unamortized discount is recognized as a reduction in the carrying value of the Senior Notes in the Consolidated Balance Sheets and is being amortized to interest expense in our Consolidated Income Statements over the expected remaining terms of the Senior Notes.
Senior Notes
On June 26, 2020, we issued 1.950% Senior Notes of $500 million aggregate principal amount due January 2028 (the “Senior Notes due 2028”) and 2.250% Senior Notes of $500 million aggregate principal amount due January 2031 (the “Senior Notes due 2031" and, together with the Senior Notes due 2028, the “Green Bond”).
The Green Bond includes covenants that restrict our ability, and the ability of our restricted subsidiaries, to incur debt secured by liens on certain property above a threshold, to engage in certain sale and leaseback transactions involving certain property above a threshold, and to consolidate or merge, or convey or transfer all or substantially all of our assets. We may redeem the Green Bond at any time, at our option, subject to certain conditions, at specified redemption prices, plus accrued and unpaid interest to the redemption date.
If a change of control triggering event (as defined in the applicable Green Bond indenture) occurs, we will be required to make an offer to purchase the notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.
Interest on the Green Bond is payable on January 30 and July 30 of each year. As of December 31, 2025, we are in compliance with all covenants for the Green Bond.
On October 11, 2016, we issued 3.250% Senior Notes of $500 million aggregate principal amount due October 2026 (the “Senior Notes due 2026”) and 4.375% Senior Notes of $400 million aggregate principal amount due October 2046 (the “Senior Notes due 2046” and, together with the Senior Notes due 2026, the “Senior Notes”).
The Senior Notes include covenants that restrict our ability, and the ability of our restricted subsidiaries, to incur debt secured by liens on certain property above a threshold, to engage in certain sale and leaseback transactions involving certain property above a threshold, and to consolidate or merge, or convey or transfer all or substantially all of our assets. We may redeem the Senior Notes, as applicable, in whole or in part, at any time at a redemption price equal to the principal amount of the Senior Notes to be redeemed, plus a make-whole premium. We may also redeem the Senior Notes in certain other circumstances, as set forth in the applicable Senior Notes indenture.
If a change of control triggering event (as defined in the applicable Senior Notes indenture) occurs, we will be required to make an offer to purchase the Senior Notes at a price equal to 101% of their principal amount plus accrued and unpaid interest to the date of repurchase.
Interest on the Senior Notes due 2026 and the Senior Notes due 2046 is payable on May 1 and November 1 of each year. As of December 31, 2025, we are in compliance with all covenants for the Senior Notes.
Credit Facilities
2023 Five-Year Revolving Credit Facility
On March 1, 2023, Xylem entered into a five-year revolving credit facility (the "2023 Credit Facility") with Citibank, N.A., as Administrative Agent, and a syndicate of lenders. The 2023 Credit Facility provides for an aggregate principal amount of up to $1 billion (available in U.S. Dollars and in Euros), with increases of up to $300 million for a maximum aggregate principal amount of $1.3 billion at the request of Xylem and with the consent of the institutions providing such increased commitments.
Interest on all loans under the 2023 Credit Facility is payable either quarterly or at the expiration of any Term SOFR or EURIBOR interest period applicable thereto. Borrowings accrue interest at a rate equal to, at Xylem's election, a base rate or an adjusted Term SOFR or EURIBOR rate plus an applicable margin. The 2023 Credit Facility includes customary provisions for implementation of replacement rates for Term SOFR-based and EURIBOR-based loans. The 2023 Credit Facility also includes a pricing grid that determines the applicable margin based on Xylem's credit rating, with a further adjustment based on Xylem's achievement of certain Environmental, Social and Governance ("ESG") key performance indicators. Xylem will also pay quarterly fees to each lender for such lender's commitment to lend accruing on such commitment at a rate based on Xylem's credit rating, whether such commitment is used or unused, as well as a quarterly letter of credit fee accruing on the letter of credit exposure of such lender during the preceding quarter at a rate based on the credit rating of Xylem with a further adjustment based on Xylem's achievement of certain ESG key performance indicators.
The 2023 Credit Facility requires that Xylem maintain a consolidated total debt to consolidated EBITDA ratio (or maximum leverage ratio), which will be based on the last four fiscal quarters. In accordance with the terms of the agreement to the 2023 Credit Facility, Xylem may not exceed a maximum leverage ratio of 4.00 to 1.00 for a period of four consecutive fiscal quarters beginning with the fiscal quarter during which a material acquisition is consummated and a maximum leverage ratio of 3.50 to 1.00 thereafter for a minimum of four fiscal quarters before another material acquisition is consummated. In addition, the 2023 Credit Facility contains a number of customary covenants, including limitations on the incurrence of secured debt and debt of subsidiaries, liens, sale and lease-back transactions, mergers, consolidations, liquidations, dissolutions and sales of assets. The 2023 Credit Facility also contains customary events of default. Xylem has the ability to designate subsidiaries that can borrow under the 2023 Credit Facility, subject to certain requirements and conditions set forth in the 2023 Credit Facility. As of December 31, 2025, the 2023 Credit Facility was undrawn, and we are in compliance with all revolver covenants. The 2023 Credit Facility has availability of $1 billion, comprised of the $1 billion aggregate principal as of December 31, 2025.
Term Loan Facility
On May 9, 2023, the Company’s subsidiary, Xylem Europe GmbH (the “Borrower”) entered into a 24-month €250 million (approximately $278 million) term loan facility (the “Term Facility”) the terms of which are set forth in a term loan agreement, among the Borrower, the Company, as parent guarantor and ING Bank. The Company has entered into a parent guarantee in favor of ING Bank also dated May 9, 2023 to secure all present and future obligations of the borrower under the Term Loan Agreement. The net cash proceeds were used to repay a portion of Evoqua’s indebtedness pursuant to the Merger Agreement.
On April 19, 2024 our Term Loan Facility was settled with cash on hand for a total of €250 million ($268 million).
Equipment Financings
The Company has secured financing agreements that require providing a security interest in specified equipment and, in some cases, the underlying contract and related receivables. As of December 31, 2025 and 2024, the gross and net amounts of those assets are included on the Consolidated Balance Sheets as follows:
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2025 | | December 31, 2024 |
| (in millions) | Gross | | Net | | Gross | | Net |
| Property, plant, and equipment, net | $ | 9 | | | $ | 2 | | | $ | 73 | | | $ | 61 | |
| Receivables, net | 1 | | | 1 | | | 3 | | | 3 | |
| Prepaid and other current assets | — | | | — | | | 5 | | | 5 | |
| Other non-current assets | — | | | — | | | 101 | | | 100 | |
| $ | 10 | | | $ | 3 | | | $ | 182 | | | $ | 169 | |
As of December 31, 2025, the future maturities of our debt were as follows:
| | | | | |
| (in millions) | Maturity |
| 2026 | $ | 534 | |
| 2027 | 11 | |
| 2028 | 508 | |
| 2029 | 1 | |
| 2030 | — | |
| Thereafter | 900 | |
| Total Future Maturities | $ | 1,954 | |
| Debt issuance costs and unamortized discount (a) | (12) | |
| Total | $ | 1,942 | |
(a)The debt issuance costs and unamortized discount is recognized as a reduction in the carrying value of the Senior Notes in the Consolidated Balance Sheets and is being amortized to interest expense in our Consolidated Income Statements over the expected remaining terms of the Senior Notes.
Commercial Paper
U.S. Dollar Commercial Paper Program
Our U.S. Dollar commercial paper program generally serves as a means of short-term funding with a $600 million maximum issuing balance and a combined limit of $1 billion inclusive of the 2023 Credit Facility. As of December 31, 2025 and 2024, none of the Company's $600 million U.S. Dollar commercial paper program was outstanding. We have the ability to continue borrowing under this program going forward in future periods.
Euro Commercial Paper Program
On June 3, 2019, Xylem entered into a Euro commercial paper program with Citigroup, as administrative agent, and a syndicate of dealers. The Euro commercial paper program provides for a maximum issuing balance of up to €500 million (approximately $589 million) which may be denominated in a variety of currencies. The maximum issuing balance may be increased in accordance with the Dealer Agreement. As of December 31, 2025 and 2024, none of the Company's Euro commercial paper program was outstanding. We have the ability to continue borrowing under this program going forward in future periods.
Note 16. Post-retirement Benefit Plans
Defined contribution plans – Xylem and certain of our subsidiaries maintain various defined contribution savings plans, which allow employees to contribute a portion of their pre-tax and/or after-tax income in accordance with specified guidelines. Several of the plans require us to match a percentage of the employee contributions up to certain limits, generally between 3.0% – 7.0% of employee eligible pay. Matching obligations, the majority of which were funded in cash in connection with the plans, and other company contributions are as follows:
| | | | | |
| (in millions) | Defined Contribution |
| 2025 | $ | 86 | |
| 2024 | 84 | |
| 2023 | 74 | |
The Xylem Stock Fund, an investment option under the defined contribution plan in which Company employees participate, is considered an Employee Stock Ownership Plan. As a result, participants in the Xylem Stock Fund may receive dividends in cash or may reinvest such dividends into the Xylem Stock Fund. Company employees held approximately 184 thousand and 204 thousand shares of Xylem Inc. common stock in the Xylem Stock Fund at December 31, 2025 and 2024, respectively.
Defined benefit pension plans and other post-retirement plans – We historically have maintained qualified and non-qualified defined benefit retirement plans covering certain current and former employees, including hourly and union plans as well as salaried plans, which generally require up to 5 years of service to be vested and for which the benefits are determined based on years of credited service and either specified rates, final pay, or final average pay. The other post-retirement benefit plans are all unfunded plans in the U.S. and Canada.
During 2025 and 2024, no plan amendments had a material impact to the Company's financial statements.
Amounts recognized in the Consolidated Balance Sheets for pension and other employee-related benefit plans (collectively, "Post-retirement Plans") reflect the funded status of the post-retirement benefit plans. The following table provides a summary of the funded status of our Post-retirement Plans, the presentation of such balances and a summary of amounts recorded within AOCL:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | December 31, 2025 | | December 31, 2024 |
| | Pension | | Other | | Total | | Pension | | Other | | Total |
| Fair value of plan assets | $ | 338 | | | $ | — | | | $ | 338 | | | $ | 301 | | | $ | — | | | $ | 301 | |
| Projected benefit obligation | (583) | | | (31) | | | (614) | | | (533) | | | (31) | | | (564) | |
| Funded status | $ | (245) | | | $ | (31) | | | $ | (276) | | | $ | (232) | | | $ | (31) | | | $ | (263) | |
| Amounts recognized in the Consolidated Balance Sheets | | | | | | | | | | | |
| Other non-current assets | $ | 71 | | | $ | — | | | $ | 71 | | | $ | 56 | | | $ | — | | | $ | 56 | |
| Accrued and other current liabilities | (14) | | | (3) | | | (17) | | | (12) | | | (3) | | | (15) | |
| Accrued post-retirement benefit obligations | (289) | | | (28) | | | (317) | | | (276) | | | (28) | | | (304) | |
| Liabilities held for sale | (13) | | | — | | | (13) | | | — | | | — | | | — | |
| Net amount recognized | $ | (245) | | | $ | (31) | | | $ | (276) | | | $ | (232) | | | $ | (31) | | | $ | (263) | |
| Accumulated other comprehensive loss: | | | | | | | | | | | |
| Net actuarial losses | $ | (39) | | | $ | (8) | | | $ | (47) | | | $ | (60) | | | $ | (8) | | | $ | (68) | |
| Prior service credit | (2) | | | — | | | (2) | | | (2) | | | 1 | | | (1) | |
| Total | $ | (41) | | | $ | (8) | | | $ | (49) | | | $ | (62) | | | $ | (7) | | | $ | (69) | |
The unrecognized amounts recorded in AOCL will be subsequently recognized as expense on a straight-line basis only to the extent they exceed 10% of the higher of the market-related value or the projected benefit obligation, over the average remaining service period of active participants, or for plans with all or substantially all inactive participants, over the average remaining life expectancy. Actuarial gains and losses incurred in future periods and not recognized as expense in those periods will initially be recognized as increases or decreases in other comprehensive income, net of tax.
The benefit obligation, fair value of plan assets, funded status, and amounts recognized in the consolidated financial statements for our defined benefit domestic and international pension plans were:
| | | | | | | | | | | | | | | | | | | | | | | |
| Domestic Plans | | International Plans |
| December 31, | | December 31, |
| (in millions) | 2025 | | 2024 | | 2025 | | 2024 |
| Change in benefit obligation: | | | | | | | |
| Benefit obligation at beginning of year | $ | 92 | | | $ | 99 | | | $ | 441 | | | $ | 483 | |
| Service cost | 2 | | | 2 | | | 10 | | | 9 | |
| Interest cost | 5 | | | 5 | | | 17 | | | 16 | |
| Benefits paid | (8) | | | (8) | | | (18) | | | (21) | |
| Actuarial loss (gain) (a) | 4 | | | (6) | | | (18) | | | (10) | |
| Plan amendments, settlements and curtailments | — | | | — | | | (3) | | | — | |
| Foreign currency translation and other | — | | | — | | | 59 | | | (36) | |
| Benefit obligation at end of year | $ | 95 | | | $ | 92 | | | $ | 488 | | | $ | 441 | |
| Change in plan assets: | | | | | | | |
| Fair value of plan assets at beginning of year | $ | 85 | | | $ | 86 | | | $ | 216 | | | $ | 210 | |
| Employer contributions | 3 | | | 5 | | | 20 | | | 17 | |
| Actual return on plan assets | 8 | | | 2 | | | 19 | | | 25 | |
| Benefits paid | (8) | | | (8) | | | (18) | | | (21) | |
| Plan amendments, settlements and curtailments | — | | | — | | | (2) | | | — | |
| | | | | | | |
| Foreign currency translation and other | — | | | — | | | 15 | | | (15) | |
| Fair value of plan assets at end of year | $ | 88 | | | $ | 85 | | | $ | 250 | | | $ | 216 | |
| Unfunded status of the plans | $ | (7) | | | $ | (7) | | | $ | (238) | | | $ | (225) | |
(a)Actuarial gains for our qualified defined benefit pension plans in 2025 primarily reflect an increase in the discount rate in 2025 as compared to 2024, which decreased benefit obligations.
The following table provides a roll-forward of the projected benefit obligation for the other post-retirement employee benefit plans:
| | | | | | | | | | | |
| (in millions) | 2025 | | 2024 |
| Change in benefit obligation: | | | |
| Benefit obligation at beginning of year | $ | 31 | | | $ | 31 | |
| | | |
| | | |
| Interest cost | 2 | | | 2 | |
| Benefits paid | (3) | | | (3) | |
| Actuarial loss | 1 | | | 1 | |
| | | |
| | | |
| Benefit obligation at the end of year | $ | 31 | | | $ | 31 | |
The accumulated benefit obligation (“ABO”) for all the defined benefit pension plans was $554 million and $518 million at December 31, 2025 and 2024, respectively.
For defined benefit pension plans in which the ABO was in excess of the fair value of the plans’ assets, the projected benefit obligation, ABO and fair value of the plans’ assets were as follows:
| | | | | | | | | | | |
| December 31, |
| (in millions) | 2025 | | 2024 |
| Projected benefit obligation | $ | 468 | | | $ | 437 | |
| Accumulated benefit obligation | 452 | | | 425 | |
| Fair value of plan assets | 161 | | | 149 | |
The components of net periodic benefit cost for our defined benefit pension plans are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Domestic defined benefit pension plans: | | | | | |
| Service cost | $ | 2 | | | $ | 2 | | | $ | 2 | |
| Interest cost | 5 | | | 5 | | | 5 | |
| Expected return on plan assets | (6) | | | (6) | | | (6) | |
| Amortization of net actuarial loss | 1 | | | 1 | | | — | |
| Net periodic benefit cost | $ | 2 | | | $ | 2 | | | $ | 1 | |
| International defined benefit pension plans: | | | | | |
| Service cost | $ | 10 | | | $ | 9 | | | $ | 7 | |
| Interest cost | 17 | | | 16 | | | 16 | |
| Expected return on plan assets | (13) | | | (13) | | | (11) | |
| | | | | |
| Amortization of net actuarial (gain) loss | — | | | — | | | (2) | |
| | | | | |
| Pension settlements and curtailments expense | 1 | | | — | | | — | |
| Net periodic benefit cost | $ | 15 | | | $ | 12 | | | $ | 10 | |
| Total net periodic benefit cost | $ | 17 | | | $ | 14 | | | $ | 11 | |
The components of net periodic benefit cost other than the service cost component are included in the line item "Other non-operating (expense) income, net" in the Consolidated Income Statements.
Other changes in plan assets and benefit obligations recognized in other comprehensive income (loss), as they pertain to our defined benefit pension plans are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Domestic defined benefit pension plans: | | | | | |
| Net loss (gain) | $ | 2 | | | $ | (2) | | | $ | 3 | |
| | | | | |
| Amortization of net actuarial gain | (1) | | | (1) | | | — | |
| Losses (gains) recognized in other comprehensive income (loss) | $ | 1 | | | $ | (3) | | | $ | 3 | |
| International defined benefit pension plans: | | | | | |
| Net (gain) loss | $ | (24) | | | $ | (22) | | | $ | 31 | |
| | | | | |
| Amortization of net actuarial loss | — | | | — | | | 2 | |
| Foreign Exchange | 2 | | | (3) | | | 2 | |
| (Gains) losses recognized in other comprehensive income (loss) | $ | (22) | | | $ | (25) | | | $ | 35 | |
| Total (gains) losses recognized in other comprehensive income (loss) | $ | (21) | | | $ | (28) | | | $ | 38 | |
| Total (gains) losses recognized in comprehensive income | $ | (4) | | | $ | (14) | | | $ | 49 | |
The components of net periodic benefit cost for other post-retirement employee benefit plans are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| | | | | |
| Interest cost | $ | 2 | | | $ | 2 | | | $ | 2 | |
| Amortization of prior service credit | (1) | | | (2) | | | (2) | |
| Amortization of net actuarial loss | 1 | | | 1 | | | — | |
| Net periodic benefit cost | $ | 2 | | | $ | 1 | | | $ | — | |
Other changes in benefit obligations recognized in other comprehensive income (loss), as they pertain to other post-retirement employee benefit plans are as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Net loss | $ | 1 | | | $ | 1 | | | $ | 1 | |
| | | | | |
| Amortization of prior service credit | 1 | | | 2 | | | 2 | |
| Amortization of net actuarial loss | (1) | | | (1) | | | — | |
| | | | | |
| Losses recognized in other comprehensive income (loss) | $ | 1 | | | $ | 2 | | | $ | 3 | |
| Total losses recognized in comprehensive income | $ | 3 | | | $ | 3 | | | $ | 3 | |
Assumptions
The following table provides the weighted-average assumptions used to determine projected benefit obligations and net periodic benefit cost, as they pertain to our pension plans.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2025 | | 2024 | | 2023 |
| | U.S. | | Int’l | | U.S. | | Int’l | | U.S. | | Int’l |
| Benefit Obligation Assumptions | | | | | | | | | | | |
| Discount rate | 5.42 | % | | 3.95 | % | | 5.65 | % | | 3.62 | % | | 5.00 | % | | 3.55 | % |
| Rate of future compensation increase | NM | | 2.87 | % | | NM | | 2.85 | % | | NM | | 2.87 | % |
| Net Periodic Benefit Cost Assumptions | | | | | | | | | | | |
| Discount rate | 5.65 | % | | 3.62 | % | | 5.00 | % | | 3.55 | % | | 5.25 | % | | 4.13 | % |
| Expected long-term return on plan assets | 6.00 | % | | 5.58 | % | | 6.00 | % | | 5.78 | % | | 6.00 | % | | 5.85 | % |
| Rate of future compensation increase | NM | | 2.85 | % | | NM | | 2.87 | % | | NM | | 2.79 | % |
NM Not meaningful. The pension benefits for future service for all the U.S. pension plans are based on years of service and not impacted by future compensation increases.
Management develops each assumption using relevant company experience in conjunction with market-related data for each individual country in which plans exist. Assumptions are reviewed annually and adjusted as necessary.
The expected long-term rate of return on assets reflects the expected returns for each major asset class in which the plans hold investments, the weight of each asset class in the target mix, the correlations among asset classes and their expected volatilities. The assets of the pension plans are held by a number of independent trustees, managed by several investment institutions and are accounted for separately in the Company’s pension funds.
Our expected return on plan assets is estimated by evaluating both historical returns and estimates of future returns. Specifically, we analyze the plans’ actual historical annual return on assets, net of fees, over the past 15, 20 and 25 years; we estimate future returns based on independent estimates of asset class returns; and we evaluate historical broad market returns over long-term timeframes based on our asset allocation range. For the U.S. Master Trust which has existed since 2011, historical returns were estimated using a constructed portfolio that reflects the Company’s strategic asset allocation and the historical compound geometric returns of each asset class for the longest time period available. Based on this approach, the weighted average expected long-term rate of return for all of our plan assets to be used in determining net periodic benefit costs for 2026 is estimated at 5.55%.
Investment Policy
The investment strategy for managing worldwide post-retirement benefit plan assets is to seek an optimal rate of return relative to an appropriate level of risk for each plan. Investment strategies vary by plan, depending on the specific characteristics of the plan, such as plan size and design, funded status, liability profile and legal requirements. In general, the plans are managed closely to their strategic allocations.
The following table provides the actual asset allocations of plan assets as of December 31, 2025 and 2024, and the related asset target allocation ranges by asset category:
| | | | | | | | | | | | | | | | | |
| 2025 | | 2024 | | Target Allocation Ranges |
| Equity securities | 36.7 | % | | 45.2 | % | | 17-55% |
| Fixed income | 44.7 | % | | 40.5 | % | | 63-77% |
| Cash, insurance contracts and other | 18.6 | % | | 14.3 | % | | 0-15% |
Fair Value of Plan Assets
In measuring plan assets at fair value, the fair value hierarchy is applied which categorizes and prioritizes the inputs used to estimate fair value into three levels. See Note 1, "Summary of Significant Accounting Policies," for further detail on fair value hierarchy.
In certain instances, fair value is estimated using quoted market prices obtained from external pricing services. In obtaining such data from the pricing service, we have evaluated the methodologies used to develop the estimate of fair value in order to assess whether such valuations are representative of fair value, including NAV.
The following is a description of the valuation methodologies and inputs used to measure fair value for major categories of investments.
•Equity securities — Equities (including common and preferred shares, domestic listed and foreign listed and closed end mutual funds) are generally valued at the closing price reported on the major market on which the individual securities are traded at the measurement date. Equity securities and mutual funds held by the Company that are publicly traded in active markets are classified within Level 1 of the fair value hierarchy. Those equities that are held in proprietary funds pooled with other investor accounts and collective trust funds measured at fair value using the NAV per share practical expedient are not classified in the fair value hierarchy.
•Fixed income — Government securities are generally valued using quoted prices of securities with similar characteristics. Corporate bonds are generally valued by using pricing models, quoted prices of securities with similar characteristics or broker quotes and are classified in Level 2. Fixed income securities held in proprietary funds pooled with other investor accounts and collective trust funds measured at fair value using the NAV per share practical expedient are not classified in the fair value hierarchy. Hedging instruments are collateralized daily with either cash or government bonds, have daily liquidity and pricing based on observable inputs from over-the-counter markets, and are classified as Level 2.
•Insurance contracts and other — Primarily comprised of insurance contracts held by foreign plans. Insurance contracts are valued on an insurer pricing basis calculated at purchase price adjusted for changes in discount rates and other actuarial assumptions or contract value, which approximates fair value. Insurance contracts are generally classified as Level 3.
•Cash — Cash and cash equivalents are held in accounts with brokers or custodians, available on demand, for liquidity and investment collateral and are classified as Level 1.
The following table provides the fair value of plan assets held by our pension benefit plans by asset class:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2025 | | 2024 |
| (in millions) | Level 1 | Level 2 | Level 3 | NAV Practical Expedient | Total | | Level 1 | Level 2 | Level 3 | NAV Practical Expedient | Total |
| Equity securities | | | | | | | | | | | |
| Global stock funds/securities | $ | 40 | | $ | 50 | | $ | — | | $ | 18 | | $ | 108 | | | $ | 42 | | $ | 65 | | $ | — | | $ | 15 | | $ | 122 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Diversified growth and income funds | — | | — | | — | | 16 | | 16 | | | — | | — | | — | | 14 | | 14 | |
| Fixed income | | | | | | | | | | | |
| Corporate bonds | 1 | | 76 | | — | | 13 | | 90 | | | 1 | | 69 | | — | | 11 | | 81 | |
| Government bonds | — | | 21 | | — | | 31 | | 52 | | | — | | 15 | | — | | 18 | | 33 | |
| Hedging instruments | — | | 9 | | — | | — | | 9 | | | — | | 8 | | — | | — | | 8 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| Insurance contracts and other | — | | — | | 51 | | 2 | | 53 | | | — | | — | | 31 | | 5 | | 36 | |
| Cash and cash equivalents | 10 | | — | | — | | — | | 10 | | | 7 | | — | | — | | — | | 7 | |
| Total plan assets subject to leveling | $ | 51 | | $ | 156 | | $ | 51 | | $ | 80 | | $ | 338 | | | $ | 50 | | $ | 157 | | $ | 31 | | $ | 63 | | $ | 301 | |
The following table presents a reconciliation of the beginning and ending balances of fair value measurement within our pension plans using significant unobservable inputs (Level 3):
| | | | | | | | |
(in millions) | | Insurance Contracts and Other |
| Balance, December 31, 2023 | | $ | 26 | |
| Purchases, sales, settlements, net | | 3 | |
| Actual return on plan assets | | 4 | |
| Currency impact | | (2) | |
| Balance, December 31, 2024 | | 31 | |
| Purchases, sales, settlements, net | | 12 | |
| Actual return on plan assets | | 3 | |
| Currency impact | | 5 | |
| Balance, December 31, 2025 | | $ | 51 | |
Contributions and Estimated Future Benefit Payments
Funding requirements under governmental regulations are a significant consideration in making contributions to our post-retirement plans. We made contributions of $26 million and $25 million to our post-retirement plans during 2025 and 2024, respectively. We currently anticipate making contributions to our post-retirement plans in the range of $19 million to $25 million during 2026, of which approximately $6 million is expected to be made in the first quarter.
The following benefit payments, which reflect expected future service, as appropriate, are expected to be paid as follows:
| | | | | | | | | | | |
| (in millions) | Pension | | Other Benefits |
| 2026 | $ | 32 | | | $ | 3 | |
| 2027 | 33 | | | 3 | |
| 2028 | 34 | | | 3 | |
| 2029 | 34 | | | 3 | |
| 2030 | 34 | | | 3 | |
| Years 2031 - 2035 | 180 | | | 11 | |
Note 17. Share-Based Compensation Plans
Our share-based compensation program is a broad-based program designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. In addition, members of our Board of Directors participate in our share-based compensation program in connection with their service on our board. Share-based awards issued to employees include non-qualified stock options, restricted stock units and performance share units. Under the 2011 Omnibus Incentive Plan, the number of shares initially available for awards was 18 million. On May 24, 2023, there were an additional 2.7 million shares registered for issuance. As of December 31, 2025, there were approximately 4.7 million shares of common stock available for future awards.
Total share-based compensation expense recognized for 2025, 2024 and 2023 was $53 million, $56 million, and $60 million, respectively. The unamortized compensation expense at December 31, 2025 related to our stock options, restricted share units and performance share units was $10 million, $36 million and $20 million, respectively, and is expected to be recognized over a weighted average period of 1.9, 1.7 and 1.8 years, respectively. See Note 5, "Restructuring and Asset Impairment Charges," for discussion of certain restructuring charges related to share-based compensation expense in 2023.
The amount of cash received from the exercise of stock options was $20 million, $67 million and $62 million for 2025, 2024 and 2023 with a tax benefit of $9 million, $19 million and $12 million, respectively, realized associated with stock option exercises and vesting of restricted stock units. We classify as an operating activity the cash flows attributable to excess tax benefits arising from stock option exercises and restricted stock unit vestings.
Stock Option Grants
Options are awarded with a contractual term of 10 years, generally vest over a three-year period and are exercisable within the contractual term, except in certain instances of termination due to death, retirement, disability and other limited circumstances in accordance with the terms of the grant agreements. The exercise price per share is the fair market value of the underlying common stock on the date each option is awarded. At December 31, 2025, there were options to purchase an aggregate of 1.1 million shares of common stock outstanding. The following is a summary of the changes in outstanding stock options for 2025:
| | | | | | | | | | | | | | | | | | | | | | | |
| Share units (in thousands) | | Weighted Average Exercise Price / Share | | Weighted Average Remaining Contractual Term (Years) | | Aggregate Intrinsic Value (in millions) |
| Outstanding at January 1, 2025 | 1,182 | | | $ | 84.76 | | | 6.3 | | $ | 40 | |
| Granted | 255 | | | 129.75 | | | | | |
| Exercised | (262) | | | 77.24 | | | | | |
| Forfeited and expired | (33) | | | 112.25 | | | | | |
| | | | | | | |
| Outstanding at December 31, 2025 | 1,142 | | | $ | 95.75 | | | 6.4 | | $ | 46 | |
| Options exercisable at December 31, 2025 | 730 | | | $ | 78.33 | | | 5.0 | | $ | 42 | |
| Vested and non-vested expected to vest as of December 31, 2025 | 1,103 | | | $ | 94.56 | | | 6.2 | | $ | 46 | |
The amount of non-vested options outstanding was 0.4 million, 0.4 million and 0.6 million at a weighted average grant date share price of $126.56, $111.88 and $88.48 as of December 31, 2025, 2024 and 2023, respectively. The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during 2025, 2024 and 2023 was $15 million, $74 million and $140 million, respectively.
The fair value of each option grant was estimated on the date of grant using the binomial lattice pricing model which incorporates multiple and variable assumptions over time, including assumptions such as employee exercise patterns, stock price volatility and changes in dividends. The following are weighted-average assumptions used for 2025, 2024, and 2023 (excluding the valuation of options granted in conjunction with the Evoqua acquisition):
| | | | | | | | | | | | | | | | | |
| | 2025 | | 2024 | | 2023 |
| Dividend yield | 1.23 | % | | 1.13 | % | | 1.31 | % |
| Volatility | 26.70 | % | | 26.70 | % | | 27.30 | % |
| Risk-free interest rate | 4.10 | % | | 4.18 | % | | 4.25 | % |
| Expected term (in years) | 5.5 | | 5.7 | | 5.4 |
| Weighted-average fair value per option | $ | 36.93 | | | $ | 38.04 | | | $ | 29.06 | |
Expected volatility is calculated based on an analysis of historic volatility measures for Xylem. We use historical data to estimate option exercise and employee termination behavior within the valuation model. The expected term represents an estimate of the period of time options are expected to remain outstanding. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of option grant.
Restricted Stock Unit Grants
Restricted stock units awarded to employees vest over a three-year period. Prior to the time a restricted stock unit becomes fully vested, the awardees cannot transfer, pledge or encumber such units. Prior to the time a restricted stock unit is fully vested, the awardees do not have certain rights of a stockholder, such as the right to vote and receive dividends; however, dividends accrue during the vesting period and are paid upon vesting. If an employee leaves prior to vesting, whether through resignation or termination for cause, the restricted stock unit and related accrued dividends are forfeited. If an employee retires prior to vesting, a pro-rata portion of the restricted stock unit may vest in accordance with the terms of the applicable grant agreements. Restricted stock units awarded to member of our Board become fully vested upon the day prior to the next annual meeting. The fair value of the restricted stock unit awards is determined using the closing price of our common stock on date of grant.
The following is a summary of the changes in outstanding restricted stock units for 2025:
| | | | | | | | | | | |
| Share Units (in thousands) | | Weighted Average Grant Date Fair Value / Share |
| Outstanding at January 1, 2025 | 632 | | | $ | 111.33 | |
| Granted | 252 | | | 130.14 | |
| Vested | (332) | | | 106.03 | |
| Forfeited | (46) | | | 120.01 | |
| Outstanding at December 31, 2025 | 506 | | | $ | 123.27 | |
Performance Share Units
Performance share units awarded under the long-term incentive plan vest based upon performance by the Company over a three-year period against targets approved by the Leadership Development & Compensation Committee of the Company's Board of Directors prior to the grant date. The performance share units were each awarded at a target of 100% with actual payout for each type of grant contingent upon the achievement of performance targets as follows:
•ROIC performance share units — a pre-set, three-year adjusted ROIC performance target
•EBITDA performance share units — a third-year adjusted EBITDA performance target
•TSR performance share units — a relative TSR performance target
•Revenue performance share units — a pre-set third year revenue target
•EPS performance share units — a cumulative three-year EPS performance target
The calculated compensation cost for ROIC, EBITDA, Revenue and EPS performance share units is adjusted based on an estimate of awards ultimately expected to vest and our assessment of the probable outcome of the performance condition.
ROIC and Adjusted EBITDA Performance Share Unit Grants
The fair value of the ROIC and adjusted EBITDA performance share unit awards is determined using the closing price of our common stock on date of grant.
The following is a summary of the changes in outstanding ROIC and EBITDA performance share units for 2025:
| | | | | | | | | | | |
| Share units (in thousands) | | Weighted Average Grant Date Fair Value / Share |
| Outstanding at January 1, 2025 | 77 | | | $ | 105.02 | |
| Granted | — | | | — | |
| Adjustment for Performance Condition Achieved (a) | 19 | | | 86.77 | |
| Vested | (44) | | | 86.77 | |
| Forfeited | (5) | | | 113.87 | |
| Outstanding at December 31, 2025 | 47 | | | $ | 113.89 | |
(a)Represents an increase in the number of original ROIC performance share units awarded based on the final performance condition achievement at the end of the performance period of such awards.
Revenue Performance Share Unit Grants
The fair value of the Revenue performance share unit awards is determined using the closing price of our common stock on date of grant.
The following is a summary of our Revenue performance share unit grants for 2025:
| | | | | | | | | | | | | | | |
| Share units (in thousands) | | | | | | Weighted Average Grant Date Fair Value / Share |
| Outstanding at January 1, 2025 | 77 | | | | | | | $ | 105.06 | |
| Granted | — | | | | | | | — | |
| Adjustment for Performance Condition Achieved (a) | 19 | | | | | | | 86.77 | |
| Vested | (44) | | | | | | | 86.77 | |
| Forfeited | (5) | | | | | | | 113.87 | |
| Outstanding at December 31, 2025 | 47 | | | | | | | $ | 113.89 | |
(a)Represents an increase in the number of original revenue performance share units awarded based on the final market condition achievement at the end of the performance period of such awards.
TSR Performance Share Unit Grants
The following is a summary of the changes in outstanding TSR performance share units for 2025:
| | | | | | | | | | | |
| Share units (in thousands) | | Weighted Average Grant Date Fair Value / Share |
| Outstanding at January 1, 2025 | 155 | | | $ | 125.42 | |
| Granted | 54 | | | 180.70 | |
| Adjustment for Market Condition Achieved (a) | (14) | | | 71.19 | |
| Vested | (37) | | | 71.19 | |
| Forfeited | (12) | | | 150.24 | |
| Outstanding at December 31, 2025 | 146 | | | $ | 157.41 | |
(a)Represents an increase in the number of original TSR performance share units awarded based on the final market condition achievement at the end of the performance period of such awards.
The fair value of TSR performance share units were calculated on the date of grant using a Monte Carlo simulation model utilizing several key assumptions, including expected Company and peer company share price volatility, correlation coefficients between peers, the risk-free rate of return, the expected dividend yield and other award design features. The following are weighted-average key assumptions for 2025 grants.
| | | | | | | | | | | | | | | | | |
| 2025 | | 2024 | | 2023 |
| Volatility | 25.8 | % | | 27.2 | % | | 35.9 | % |
| Risk-free interest rate | 4.01 | % | | 4.33 | % | | 4.66 | % |
| | | | | |
| | | | | |
EPS Performance Share Unit Grants
The fair value of the earnings per share ("EPS") performance share unit awards is determined using the closing price of our common stock on date of grant.
The following is a summary of the changes in outstanding EPS performance share units for 2025:
| | | | | | | | | | | |
| Share units (in thousands) | | Weighted Average Grant Date Fair Value / Share |
| Outstanding at January 1, 2025 | — | | | $ | — | |
| Granted | 54 | | | 129.81 | |
| Vested | — | | | — | |
| Forfeited | (2) | | | 129.67 | |
| Outstanding at December 31, 2025 | 52 | | | $ | 129.82 | |
Note 18. Capital Stock
The Company has the authority to issue an aggregate of 750 million shares of common stock having a par value of $0.01 per share. The shareholders of Xylem common stock are entitled to receive dividends as declared by the Xylem Board of Directors. Dividends declared were $1.60, $1.44 and $1.32 during 2025, 2024 and 2023, respectively.
The changes in shares of common stock outstanding for the three years ended December 31 are as follows:
| | | | | | | | | | | | | | | | | |
| (share units in thousands) | 2025 | | 2024 | | 2023 |
| Beginning Balance, January 1 | 242,985 | | | 241,504 | | | 180,253 | |
| Shares issued for the Evoqua acquisition (a) | — | | | — | | | 58,779 | |
| Stock incentive plan net activity | 718 | | | 1,637 | | | 2,730 | |
| Repurchase of common stock | (119) | | | (156) | | | (258) | |
| Ending Balance, December 31 | 243,584 | | | 242,985 | | | 241,504 | |
(a)See Note 3 "Acquisitions and Divestitures" for further information.
For the years ended December 31, 2025 and December 31, 2024, the Company repurchased 0.1 million shares of common stock for $15 million and repurchased 0.2 million shares of common stock for $20 million, respectively. Repurchases include both share repurchase programs approved by the Board of Directors and repurchases in relation to settlement of employee tax withholding obligations due as a result of the vesting of restricted stock units. The detail of repurchases by each program are as follows:
On August 24, 2015, our Board of Directors authorized the repurchase of up to $500 million in shares with no expiration date. The program's objective is to deploy our capital in a manner that benefits our shareholders and maintains our focus on growth. For the years ended December 31, 2025 and December 31, 2024 there were no shares repurchased under the program. There are up to $182 million in shares that may still be purchased under this plan as of December 31, 2025.
Aside from the aforementioned repurchase programs, we repurchased approximately 0.1 million and approximately 0.2 million shares for $15 million and $20 million during 2025 and 2024, respectively, in relation to settlement of employee income tax withholding obligations due as a result of the vesting of restricted stock units. The shares repurchased are included in the stock incentive plan net activity in the above table.
Note 19. Accumulated Other Comprehensive Loss
The following table provides the components of accumulated other comprehensive loss for 2025, 2024 and 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Foreign Currency Translation | | Post-retirement Benefit Plans | | Derivative Instruments | | Total | | |
| Balance at January 1, 2023 | $ | (180) | | | $ | (41) | | | $ | (5) | | | $ | (226) | | | |
| Foreign currency translation adjustment | (45) | | | | | | | (45) | | | |
| Income tax impact on foreign currency translation adjustment | 29 | | | | | | | 29 | | | |
| Changes in post-retirement benefit plans | | | (35) | | | | | (35) | | | |
| | | | | | | | | |
| | | | | | | | | |
| Foreign currency translation adjustment for post-retirement benefit plans | | | (2) | | | | | (2) | | | |
| Income tax expense on changes in post-retirement benefit plans, including settlement | | | 9 | | | | | 9 | | | |
| | | | | | | | | |
| Amortization of prior service cost and net actuarial loss on post-retirement benefit plans into other non-operating income (expense), net | | | (4) | | | | | (4) | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| Income tax impact on amortization of post-retirement benefit plan items | | | 1 | | | | | 1 | | | |
| Unrealized loss on derivative hedge agreements | | | | | (2) | | | (2) | | | |
| Tax on unrealized loss on derivative hedge agreements | | | | | (1) | | | (1) | | | |
| Reclassification of unrealized loss on foreign exchange agreements into revenue | | | | | 3 | | | 3 | | | |
| Reclassification of unrealized loss on foreign exchange agreements into cost of revenue | | | | | 4 | | | 4 | | | |
| Balance at December 31, 2023 | $ | (196) | | | $ | (72) | | | $ | (1) | | | $ | (269) | | | |
| Foreign currency translation adjustment | (157) | | | | | | | (157) | | | |
| Income tax impact on foreign currency translation adjustment | (15) | | | | | | | (15) | | | |
| Changes in post-retirement benefit plans | | | 23 | | | | | 23 | | | |
| | | | | | | | | |
| Foreign currency translation adjustment for post-retirement benefit plans | | | 3 | | | | | 3 | | | |
| | | | | | | | | |
| | | | | | | | | |
| Income tax impact on amortization of post-retirement benefit plan items | | | (7) | | | | | (7) | | | |
| Unrealized loss on derivative hedge agreements | | | | | (17) | | | (17) | | | |
| Tax on unrealized loss on derivative hedge agreements | | | | | 2 | | | 2 | | | |
| Reclassification of unrealized loss on foreign exchange agreements into revenue | | | | | 1 | | | 1 | | | |
| Reclassification of unrealized loss on foreign exchange agreements into cost of revenue | | | | | 1 | | | 1 | | | |
| Balance at December 31, 2024 | $ | (368) | | | $ | (53) | | | $ | (14) | | | $ | (435) | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Foreign Currency Translation | | Post-retirement Benefit Plans | | Derivative Instruments | | Total | | |
| Foreign currency translation adjustment | 86 | | | | | | | 86 | | | |
| Amount of currency translation adjustment relating to divestiture of foreign subsidiaries reclassified into net income | 8 | | | | | | | 8 | | | |
| Income tax impact on foreign currency translation adjustment | 83 | | | | | | | 83 | | | |
| Changes in post-retirement benefit plans | | | 21 | | | | | 21 | | | |
| | | | | | | | | |
| Foreign currency translation adjustment for post-retirement benefit plans | | | (2) | | | | | (2) | | | |
| | | | | | | | | |
| Amortization of prior service cost and net actuarial gain on post-retirement benefit plans into other non-operating income (expense), net | | | 1 | | | | | 1 | | | |
| Income tax impact on amortization of post-retirement benefit plan items | | | (6) | | | | | (6) | | | |
| Unrealized gain on derivative hedge agreements | | | | | 35 | | | 35 | | | |
| Tax on unrealized gain on derivative hedge agreements | | | | | (2) | | | (2) | | | |
| Reclassification of unrealized gain on foreign exchange agreements into revenue | | | | | (4) | | | (4) | | | |
| Reclassification of unrealized gain on foreign exchange agreements into cost of revenue | | | | | (5) | | | (5) | | | |
| Balance at December 31, 2025 | $ | (191) | | | $ | (39) | | | $ | 10 | | | $ | (220) | | | |
Note 20. Commitments and Contingencies
Legal Proceedings
From time to time, we are involved in legal and regulatory proceedings that are incidental to the operation of our businesses (or the business operations of previously owned entities). These proceedings may seek remedies relating to matters including environmental, tax, intellectual property, acquisitions or divestitures, product liability, property damage, personal injury, privacy, employment, labor and pension, government investigations or contract issues and commercial or contractual disputes.
See Note 7, "Income Taxes," for a description of a pending tax litigation matter.
Although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including our assessment of the merits of the particular claims, we do not believe it is reasonably possible that any asserted or unasserted legal claims or proceedings, individually or in aggregate, will have a material adverse effect on our results of operations, or financial condition.
We have estimated and accrued $4 million as of both December 31, 2025 and 2024 for these general legal matters.
Unconditional Purchase Obligations
We have future unconditional purchase commitments which are legally binding and that specify all significant terms including price and/or quantity. Total future commitments for these obligations is $802 million, of which $775 million is committed within the next twelve months, excluding contracts that can be canceled without penalty.
Guarantees
We obtain certain stand-by letters of credit, bank guarantees, surety bonds and insurance letters of credit from third-party financial institutions in the ordinary course of business when required under contracts or to satisfy insurance related requirements. As of December 31, 2025 and 2024, the amount of surety bonds, bank guarantees, insurance letters of credit and stand-by letters of credit was $822 million and $758 million, respectively.
Environmental
In the ordinary course of business, we are subject to federal, state, local, and foreign environmental laws and regulations. We are responsible, or are alleged to be responsible, for ongoing environmental investigation and remediation of sites in various countries. Our accrued liabilities represent our best estimates related to the investigation and remediation of environmental media such as water, soil, soil vapor, air and structures, as well as related legal fees. Liabilities for these environmental expenditures are recorded on an undiscounted basis. We have estimated and accrued $4 million as of both December 31, 2025 and 2024, respectively, for environmental matters.
Given the complexities and uncertainties involved in on-going and future investigation and remediation projects, the process to estimate environmental remediation liabilities requires judgment. We believe the total amount accrued is reasonable based on existing facts and circumstances.
Warranties
We warrant numerous products, the terms of which vary widely. In general, we warrant products against defects and specific non-performance. Warranty expense was $39 million, $36 million, and $29 million for 2025, 2024 and 2023, respectively. The table below provides changes in the combined current and non-current product warranty accruals over each period.
| | | | | | | | | | | | | | | | | |
| (in millions) | 2025 | | 2024 | | 2023 |
| Warranty accrual – January 1 | $ | 57 | | | $ | 63 | | | $ | 54 | |
| Net charges for product warranties in the period | 39 | | | 36 | | | 29 | |
| Net Evoqua additions from acquisition | — | | | — | | | 10 | |
| Settlement of warranty claims | (34) | | | (37) | | | (32) | |
| Transfers related to assets held for sale | (8) | | | (2) | | | — | |
| Foreign currency and other | (1) | | | (3) | | | 2 | |
| Warranty accrual – December 31 | $ | 53 | | | $ | 57 | | | $ | 63 | |
Note 21. Segment and Geographic Data
Our business has four reportable segments: Water Infrastructure, Applied Water, Measurement and Control Solutions and Water Solutions and Services. The Water Infrastructure segment focuses on the transportation and treatment of water, offering a range of products including water, wastewater and storm water pumps, controls and systems; and treatment equipment: filtration and separation, disinfection, wastewater solutions for municipal and industrial applications. The Applied Water segment serves many of the primary uses of water and focuses on the residential, commercial and industrial markets. The Applied Water segment's major products include pumps, valves, heat exchangers, controls and dispensing equipment. The Measurement and Control Solutions segment focuses on developing advanced technology solutions that enable intelligent use and conservation of critical water and energy resources as well as analytical instrumentation used in the testing of water. The Measurement and Control Solutions segment's major products include smart metering, networked communications, measurement and control technologies, critical infrastructure technologies, software and services including cloud-based analytics, and remote monitoring and data management. The Water Solutions and Services segment provides tailored services and solutions, in collaboration with customers and backed by life‑cycle services, including on‑demand water, outsourced water, recycle/reuse, specialty dewatering and emergency response service alternatives to improve operational reliability, performance and environmental compliance. Key offerings within this segment also include equipment systems for industrial needs (influent water, boiler feed water, ultrahigh purity, process water, wastewater treatment, and recycle/reuse), full-scale outsourcing of operations and maintenance, and municipal services, including odor and corrosion control services, as well as leak detection, condition assessment and asset management and pressure monitoring solutions.
Corporate and other consists of corporate office expenses including compensation, benefits, occupancy, depreciation, and other administrative costs, as well as charges related to certain matters that are managed at a corporate level and are not included in the business segments in evaluating performance or allocating resources. The accounting policies of each segment are the same as those described in the summary of significant accounting policies (see Note 1, "Summary of Significant Accounting Policies").
The chief operating decision maker (“CODM”) for the Company is our President and Chief Executive Officer. The CODM uses segment operating income/(loss) as a primary factor in allocating resources to the segments. The CODM considers budget-to-actual variances on a quarterly basis for the profit measure to assess segment performance. Disaggregated asset information by segment is not provided to the CODM for review, therefore, such information is not presented.
The following tables contain financial information provided to the CODM for each reportable segment:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Water Infrastructure | | Applied Water | | Measurement and Control Solutions | | Water Solutions and Services | | Total |
| Balance for year ended December 31, 2025 | | | | | | | | | |
| Revenue | $ | 2,636 | | | $ | 1,849 | | | $ | 2,086 | | | $ | 2,464 | | | $ | 9,035 | |
| Less: | | | | | | | | | |
| Adjusted cost of revenue (a) | 1,440 | | | 1,180 | | | 1,285 | | | 1,578 | | | |
| Adjusted operating expenses (a) | 613 | | | 329 | | | 448 | | | 464 | | | |
| Other segment items (b) | 121 | | | 28 | | | 109 | | | 120 | | | |
| Segment operating income | $ | 462 | | | $ | 312 | | | $ | 244 | | | $ | 302 | | | $ | 1,320 | |
| Reconciliation of segment operating income | | | | | | | | | |
| Corporate and other loss | | | | | | | | | (97) | |
| Interest expense | | | | | | | | | (29) | |
| | | | | | | | | |
| Other non-operating income, net | | | | | | | | | 18 | |
| Loss on sale of businesses | | | | | | | | | (31) | |
| Income before income taxes | | | | | | | | | $ | 1,181 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Water Infrastructure | | Applied Water | | Measurement and Control Solutions | | Water Solutions and Services | | Total |
| Balance for year ended December 31, 2024 | | | | | | | | | |
| Revenue | $ | 2,555 | | | $ | 1,793 | | | $ | 1,871 | | | $ | 2,343 | | | $ | 8,562 | |
| Less: | | | | | | | | | |
| Adjusted cost of revenue (a) | 1,460 | | | 1,162 | | | 1,128 | | | 1,521 | | | |
| Adjusted operating expenses (a) | 640 | | | 345 | | | 416 | | | 454 | | | |
| Other segment items (b) | 99 | | | 15 | | | 80 | | | 149 | | | |
| Segment operating income | $ | 356 | | | $ | 271 | | | $ | 247 | | | $ | 219 | | | $ | 1,093 | |
| Reconciliation of segment operating income | | | | | | | | | |
| Corporate and other loss | | | | | | | | | (84) | |
| Interest expense | | | | | | | | | (44) | |
| Gain on remeasurement of previously held equity interest | | | | | | | | | 152 | |
| Other non-operating income, net | | | | | | | | | 16 | |
| Loss on sale of businesses | | | | | | | | | (46) | |
| Income before income taxes | | | | | | | | | $ | 1,087 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (in millions) | Water Infrastructure | | Applied Water | | Measurement and Control Solutions | | Water Solutions and Services | | Total |
| Balance for year ended December 31, 2023 | | | | | | | | | |
| Revenue | $ | 2,215 | | | $ | 1,853 | | | $ | 1,612 | | | $ | 1,684 | | | $ | 7,364 | |
| Less: | | | | | | | | | |
| Adjusted cost of revenue (a) | 1,277 | | | 1,195 | | | 990 | | | 1,093 | | | |
| Adjusted operating expenses (a) | 570 | | | 334 | | | 409 | | | 345 | | | |
| Other segment items (b) | 93 | | | 14 | | | 80 | | | 114 | | | |
| Segment operating income | $ | 275 | | | $ | 310 | | | $ | 133 | | | $ | 132 | | | $ | 850 | |
| Reconciliation of segment operating income | | | | | | | | | |
| Corporate and other loss | | | | | | | | | (198) | |
| Interest expense | | | | | | | | | (49) | |
| | | | | | | | | |
| Other non-operating income, net | | | | | | | | | 33 | |
| Loss on sale of businesses | | | | | | | | | (1) | |
| Income before income taxes | | | | | | | | | $ | 635 | |
(a)Adjusted costs of revenue and adjusted operating expenses represent segment-level information that are regularly provided to the CODM. These balances represent costs of revenue and operating expenses, respectively, adjusted to exclude purchase accounting intangible amortization, restructuring and realignment expenses, and special charges.
(b)Other segment items for each segment represents purchase accounting intangible amortization, restructuring and realignment expenses, and special charges, which are excluded from the above significant expense categories regularly provided to the CODM in line with our adjusted measures as outlined in Item 7 "Management's Discussion and Analysis of Financial Condition and Results of Operations" in this Annual Report on Form 10-K.
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| Depreciation and amortization: | | | | | |
| Water Infrastructure | $ | 98 | | | $ | 122 | | | $ | 89 | |
| Applied Water | 33 | | | 28 | | | 28 | |
| Measurement and Control Solutions | 168 | | | 132 | | | 124 | |
| Water Solutions and Services | 267 | | | 267 | | | 184 | |
| | | | | |
| Corporate and other | 9 | | | 13 | | | 11 | |
| Total | $ | 575 | | | $ | 562 | | | $ | 436 | |
| Capital expenditures: | | | | | |
| Water Infrastructure | $ | 38 | | | $ | 36 | | | $ | 36 | |
| Applied Water | 34 | | | 22 | | | 32 | |
| Measurement and Control Solutions | 76 | | | 71 | | | 62 | |
| Water Solutions and Services | 123 | | | 148 | | | 106 | |
Centralized support facilities (a) | 33 | | | 20 | | | 20 | |
| Corporate and other | 27 | | | 24 | | | 15 | |
| Total | $ | 331 | | | $ | 321 | | | $ | 271 | |
(a) Represents capital expenditures incurred by the centralized support facilities that are not allocated to the segments.
Geographical Information
Revenue is attributed to countries based upon the location of the customer. Property, Plant & Equipment is attributed to countries based upon the location of the assets:
| | | | | | | | | | | | | | | | | |
| | Revenue |
| Year Ended December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
United States | $ | 5,209 | | | $ | 4,862 | | | $ | 3,956 | |
Western Europe | 1,839 | | | 1,745 | | | 1,655 | |
Emerging Markets | 1,221 | | | 1,274 | | | 1,182 | |
Other | 766 | | | 681 | | | 571 | |
| Total | $ | 9,035 | | | $ | 8,562 | | | $ | 7,364 | |
| | | | | | | | | | | | | | | | | |
| Property, Plant & Equipment |
| December 31, |
| (in millions) | 2025 | | 2024 | | 2023 |
| United States | $ | 719 | | | $ | 732 | | | $ | 725 | |
| Western Europe | 245 | | | 258 | | | 268 | |
| Emerging Markets | 167 | | | 132 | | | 141 | |
| Other | 28 | | | 30 | | | 35 | |
| Total | $ | 1,159 | | | $ | 1,152 | | | $ | 1,169 | |
Note 22. Redeemable Non-controlling Interests
The holders of the non-controlling interest in Idrica, a consolidated subsidiary of the Company, have a right to sell the remaining equity interest in Idrica to the Company for cash (the “Put Right”). The Put Right is exercisable after December 10, 2027 and has a fixed strike price of €168 million during the first two years after it is exercisable. Beginning in the third year of exercisability, the Put Right is exercisable at the fair market value of underlying equity interests. Redeemable non-controlling interest is reflected in the consolidated balance sheets at the greater of the carrying value or the redemption value. As of December 31, 2025, the Redeemable Non-Controlling Interest is reflected in the consolidated balance sheet at its carrying value.
The following table presents changes in redeemable noncontrolling interests for the year ended December 31, 2025. Change in redeemable noncontrolling interest between the acquisition date of Idrica and December 31, 2024 was not material.
| | | | | | | | |
| (in millions) | | |
| Balance at December 31, 2024 | | $ | 235 | |
| Net loss attributable to non-controlling interest | | (7) | |
| Cumulative translation adjustment | | 30 | |
| Balance at December 31, 2025 | | $ | 258 | |